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Abstract		 	 Fever	is	a	common	chief	complaint	and	concern	of	parents	in	the	pediatric	population.		Urgent	care	clinics	commonly	treat	pediatric	patients	with	fever	and	must	also	deal	with	an	inappropriate	parental	knowledge	base	(Martins	&	Abecasis,	2016;	Purssell,	2008;	Wallenstein	et	al.,	2012;	Walsh,	Edwards,	&	Fraser,	2007;	Walsh,	Edwards,	&	Fraser,	2008).		The	purpose	of	this	evidence-based	project	was	to	design	and	implement	a	pediatric	antipyretic	guideline	and	fever	facts	sheet	to	increase	recognition	and	the	use	of	appropriate	antipyretic	treatments	in	the	clinical	and	home	settings.			
	 This	project	was	implemented	using	the	ACE	Star	Model	of	Knowledge	Transformation	at	the	Urgent	Care	Wailea	Makena	(UCWM),	using	a	pretest–posttest	design	to	evaluate	the	innovations’	impact	on	the	outcomes.		The	practice	change	was	an	implementation	of	a	protocol	algorithm	and	an	educational	handout	to	address	pediatric	fever,	which	did	not	previously	exist.	Both	innovations	assured	consistent	evidence-based	information	would	be	followed	and	discussed	with	the	parents	of	the	pediatric	patients	in	the	clinic	at	the	time	of	care.				 Historical	data,	from	2015	and	2016,	was	compared	to	post-implementation	data	collected	from	July	2017	through	October	2017.		Data	elements	were	taken	from	charts,	then	compared	and	analyzed.			 The	results	suggest	that	the	antipyretic	guideline	and	fever	facts	sheet	were	successful	in	improving	the	recognition	and	appropriate	treatment	of	fever	in	the	pediatric	patient	aged	six	months	to	six	years	in	an	urgent	care	setting.		It	also	suggests	that	health	care	team	members	and	parents/caregivers	of	pediatric	
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patients	are	receptive	to	improving	and	updating	their	knowledge	of	pediatric	fever	treatments.		
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Chapter	1:	Executive	Summary	
	 Pediatric	fever	is	a	misunderstood	symptom,	causing	anxiety	in	parents	and	caregivers,	which	results	in	inappropriate	actions	based	on	fever	phobia	and	incorrect	information	(Martins	&	Abecasis,	2016;	Purssell,	2008;	Wallenstein	et	al.,	2012;	Walsh	et	al.,	2007;	Walsh	et	al.,	2008).		Urgent	Care	Wailea	Makena	did	not	have	a	guideline	for	recognizing,	treating	or	educating	parents	about	pediatric	fever.		The	lack	of	guideline	opens	the	clinic	up	for	inconsistent	care	and	inappropriate	treatment,	especially	when	dealing	with	parents	who	base	their	decisions	on	fear	and	incorrect	information.		
	 This	project	used	the	Academic	Center	for	Evidence-Based	Practice	(ACE)	Star	Model	of	Knowledge	Transformation,	which	facilitates	evidence-based	innovations	into	clinical	practice.		The	goal	was	to	improve	clinical	practice,	consistency	of	care,	and	parental	knowledge	of	fever	treatment.	
	 The	literature	review	focuses	on	the	definition	of	fever,	antipyretic	treatments,	and	fever	phobia/caregiver	knowledge.		These	topics	helped	to	guide	the	development	of	the	two	innovations:	the	pediatric	antipyretic	guideline	and	fever	facts	sheet.	
	 The	innovations	focused	on	improving	recognition	and	appropriate	treatment	of	pediatric	fever	in	the	clinic	and	at	home.		The	underlying	goal	was	to	assimilate	evidence-based	knowledge	into	the	clinical	and	home-based	decision-making	process	regarding	pediatric	fever.	
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Methods	
	 The	project	took	existing	data	elements	and	compared	them	to	the	corresponding	data	elements	collected	after	the	implementation	of	the	innovations.		The	practice	change	was	an	implementation	of	an	evidence-based	protocol	to	address	the	febrile	pediatric	child	in	the	clinic	and	establish	consistency	in	febrile	education	for	the	parents	of	the	pediatric	patients.		Previous	to	this	project,	there	had	been	no	established	protocol	to	address	these	situations	at	the	clinical	site.		 Urgent	Care	Wailea	Makena	(UCWM)	is	a	clinic	on	Maui	that	primarily	helps	the	visitors	to	the	island.		The	target	populations	for	this	project	were	parents	of	febrile	pediatric	patients	aged	six	months	to	six	years	of	age,	presenting	with	uncomplicated	illness,	and	the	health	care	team	who	took	care	of	the	target	pediatric	population.		Both	of	these	populations	were	present	at	Urgent	Care	Wailea	Makena,	during	the	implementation	and	evaluation	of	the	innovation,	which	was	July	through	October	2017.		 Data	were	collected	from	the	charts	of	pediatric	patients	meeting	the	eligibility	criteria.		Data	were	analyzed	to	determine	any	trends	in	behavior	change	of	the	parents	and	the	health	care	team	by	the	Doctorate	of	Nursing	Practice	(DNP)	student	with	the	help	of	the	health	care	team	members	at	UCWM.		Once	finished,	the	findings	are	being	disseminated	and	a	plan	for	long-term	sustainability	is	being	developed.	
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Results	
Description	of	Participants		 The	pediatric	patients	were	predominantly	visitors	(95%)	to	the	island,	United	State	citizens	(82%),	and	diagnosed	with	acute	otitis	media	(66%),	acute	pharyngitis	(20%),	or	acute	sinusitis	(9%).			These	patients’	families	are	generally	from	a	higher	socioeconomic	status	and	have	a	higher	level	of	education.	
Data	Analyses	Findings		 The	health	care	team	objective	to	appropriately	recognize	and	treat	pediatric	fever	was	reached	100%	of	the	time.		The	parent/caregiver	objective	to	appropriately	recognize	and	treat	fever	at	home	was	met	during	the	months	of	September	and	October,	as	well	as	during	the	four-month	overall	total,	however	it	failed	to	reach	the	goal	for	the	months	of	July	and	August.	
Discussion	
Interpretation	of	Results		 The	results	suggest	that	both	tools,	the	antipyretic	guideline	and	the	fever	facts	sheet,	are	able	to	improve	health	care	team	members’	and	parent/caregivers’	ability	to	choose	evidence-based	appropriate	antipyretic	treatments	for	the	pediatric	patient.		The	results	also	suggest	that	health	care	team	members	and	parents/caregivers	are	receptive	to	updating	their	knowledge	and	understanding	of	pediatric	fever	and	how	to	address	it.		Finally,	the	results	also	demonstrate	that	parents	and	caregivers	of	pediatric	patients	are	improving	their	adherence	to	the	evidence-based	guidelines	over	the	past	few	years,	but	that	there	is	still	progress	to	be	made.	
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Implications	
	 These	findings	suggest	that	pediatric	fever	can	be	appropriately	addressed	in	the	urgent	care	setting	as	well	as	at	home.		To	be	successful,	the	health	care	team	and	parents/caregivers	need	to	work	together	and	utilize	evidence-based	tools	to	guide	their	treatment	choices.	
Limitations		 Limitations	found	during	this	DNP	project	were	time	(e.g.	seasonal	constraints	and	contact	time	between	the	health	care	team	and	parents/caregivers),	parental	reporting	bias,	and	sample	size.		Results	may	also	be	skewed	due	to	the	homogeneity	of	the	patients’	socioeconomic	status	and	parents’	education	level.														
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Chapter	2:	Problem	Fever	is	a	common	complaint	for	pediatric	patients	presenting	in	the	clinical	setting.		It	is	not	well	understood	by	many	parents	or	caregivers,	resulting	in	fear	on	the	part	of	both	groups	and	the	potential	for	inappropriate	treatments	(Martins	&	Abecasis,	2016;	Purssell,	2008;	Wallenstein	et	al.,	2012;	Walsh	et	al.,	2007;	Walsh	et	al.,	2008).		Fever	needs	to	be	formally	addressed	in	a	consistent	manner	to	help	alleviate	these	misconceptions	and	fears,	as	well	as	provide	appropriate	evidence-based	treatments	(Anderson,	Rolfe,	&	Brennan-Hunter,	2013;	Krantz,	2001;	Walsh	et	al.,	2007;	Walsh	et	al.,	2008).		This	chapter	will	provide	a	background	about	this	problem,	present	what	research	has	found	about	pediatric	fever	and	its	treatment,	and	present	a	guideline	to	help	choose	the	appropriate	fever	therapies	and	improve	parents’/caregivers’	knowledge	and	treatment	choices.			
Definitions	
	 There	are	several	key	terms	that	are	used	throughout	the	body	of	this	text.		It	is	important	to	understand	how	they	are	defined	for	this	project.	
• Discomfort	–	Mental	or	physical	uneasiness	(Merriam-Webster,	2017).	
• Fever	–	Tympanic	temperature	of	≥100.4	°F	or	38	°C,	axilla	temperature	of	≥99	°F	or	37.3	°C,	oral	temperature	of	≥100	°F	or	37.7	°C	(Ward,	2017).		For	this	project,	a	tympanic	temperature	will	be	the	preferred	method	due	to	a	pre-established	clinical	protocol	used	by	UCWM.	
• Fever	phobia	–	An	exaggerated	and	unrealistic	fear	of	fever	expressed	by	parents	and	caregivers	(Purssell	&	Collin,	2016)	
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• Illness	–	Poor	health	resulting	from	disease	of	body:	sickness	(Medical	Dictionary,	2017).	
• Uncomplicated	–	Not	involving	medical	complications,	i.e.	not	requiring	hospitalization,	extended	observation,	or	specialty	care	(Medical	Dictionary,	2017).	
Conceptual	Model			 The	conceptual	model	that	was	used	is	the	ACE	Star	Model	of	Knowledge	Transformation.		The	model	provided	a	framework	for	this	project	that	facilitated	an	efficient	transfer	of	research	into	clinical	practice.		The	knowledge-transfer	goal	was	accomplished	by	discovering	a	need	for	knowledge,	summarizing	all	of	the	relevant	evidence-based	research,	translating	it	into	a	guideline,	implementing	the	guideline	in	the	UCWM	practice,	and	then	evaluating	the	outcomes	(Stevens,	2013).		The	result	was	a	loose	framework,	as	depicted	in	figure	1,	that	was	designed	to	construct	and	implement	a	guideline,	without	being	too	intrusive	on	the	process	itself.									
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Figure	1.	ACE	Star	Model	of	EBP:	Knowledge	Transformation	(Stevens,	2004)																																			
	
Background		 Fever	is	one	of	the	most	common	chief	complaints	in	the	United	States	(US).		In	2012	it	accounted	for	1.2%	of	all	office	visits,	making	it	the	eighth	most	common	symptom	reported	as	a	chief	complaint	(Centers	for	Disease	Control	[CDC],	2012).		This	is	consistent	with	outpatient	data	from	2011,	where	fever	also	accounted	for	1.2%	of	all	outpatient	patient	visits,	making	it	in	the	fourth	most	common	symptom	reported	as	a	chief	complaint	(CDC,	2011).		It	is	estimated	there	are	60	million	annual	pediatric	visits	for	fever	(Wallenstein	et	al.,	2012).		These	account	for	about	30%	of	the	visits	for	an	acute	care	issue	to	health	care	providers	(Crocetti,	Moghbeli,	&	Serwint,	2001;	Wallenstein	et	al.,	2012).	This	is	a	high	number	of	visits	because	fever	is	an	underlying	symptom	that	is	associated	with	many	different	diagnoses.		
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Even	though	it	is	a	symptom	of	a	disease	process,	many	parents	and	caregivers	focus	only	on	the	fever	itself.		Anxiety	runs	high	and	many	caregivers	feel	that	the	child	needs	to	have	a	consistently	normal	temperature,	regardless	of	the	intensity	of	the	fever	or	the	circumstance	that	causes	the	fever.		This	becomes	a	bigger	problem	when	the	definition	of	a	fever	is	unclear,	interventions	are	inappropriate,	and	actions	are	motivated	by	fever	phobia	(Martins	&	Abecasis,	2016;	Purssell,	2008;	Wallenstein	et	al.,	2012;	Walsh	et	al.,	2008).		 The	definition	of	fever	is	often	undefined	for	the	caregiver,	leaving	them	confused	and	unsure	about	actual	values.		It	is	generally	accepted	by	the	medical	community	that	a	fever	is	any	temperature	over	100.4°F	rectally	or	tympanically;	100°F	orally;	and	99°F	via	axillary	measurement	(McDougall	&	Harrison,	2014;	Schmitt,	2015;	Ward,	2017).		However,	when	polled,	44%	to	100%	of	parents	and	caregivers	were	found	to	give	incorrect	values	for	an	elevated	temperature	(Crocetti	et	al.,	2001;	Demir	&	Sekreter,	2012;	Wallenstein	et	al.,	2012).		If	the	acceptable	values	for	an	abnormal	temperature	are	not	established	and	understood	there	is	no	foundation	for	the	proper	identification	and	treatment	of	a	fever	(Martins	&	Abecasis,	2016;	Wallenstein	et	al.,	2012;	Walsh	et	al.,	2007).		 Research	has	shown	that	parental	and	caregiver	antipyretic	medication	use	is	often	outdated	and	fueled	by	fears,	rather	than	scientific	evidence.		It	has	been	found	that	fever	does	not	cause	long-term	neurologic	issues,	is	beneficial	to	combatting	an	infection,	and	can	help	to	develop	an	individual’s	immunity	(Crocetti	et	al.,	2001;	El-Radhi,	2008;	Purssell	&	Collin,	2016;	Sullivan	&	Farrar,	2011).		Antipyretic	medications	do	not	prevent	febrile	seizures	(El-Radhi	&	Barry,	2003),	
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nor	have	they	been	found	to	speed	recovery	from	the	underlying	cause	of	the	increased	temperature	associated	with	the	condition	(El-Radhi	&	Sahib,	2008).		Fever	phobia	is	resulting	in	increased	use	of	antipyretics	and	combinations	of	medications	(El-Radhi	&	Sahib,	2008;	Purssell,	2008),	even	though	the	American	Academy	of	Pediatrics	and	the	Italian	Pediatric	Society	guidelines’	recommendations	are	to	only	treat	a	fever	in	the	presence	of	discomfort	(Chiappini	et	al.,	2016;	McDougall	&	Harrison,	2014;	Sullivan	&	Farrar,	2011).		It	is	essential	that	providers	fully	understand	the	current	recommendations	about	pediatric	fever	management	so	they	can	integrate	these	into	patient	education,	resulting	in	decreased	fever	phobia	and	unnecessary	antipyretic	treatments	in	the	pediatric	populations.		 The	UCWM	does	not	have	a	guideline	for	diagnosing,	treating,	or	educating	parents	about	pediatric	fever,	which	is	a	problem	that	presents	in	the	clinic	20	to	30	times	a	month,	depending	on	the	time	of	year.		The	most	common	diagnoses	for	children	at	this	clinic	include	acute	otitis	media,	acute	sinusitis,	and	fever.		The	chief	complaint	for	the	aforementioned	diagnoses	is	fever.		Because	of	this,	there	is	an	obligation	to	provide	evidence-based	education	to	the	parents	and	help	to	dispel	pediatric	fever	treatment	outdated	practices.		A	clinical	guideline	that	is	based	on	current	evidence	about	the	treatment	of	children’s	fever	will	help	to	clarify	the	current	standards	for	antipyretic	use	in	children	and	decrease	unnecessary	calls	to	the	clinic.		
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Search	Strategy		 An	electronic	search	of	databases	was	conducted	that	included	PubMed,	CINAHL,	Cochrane	Library,	and	the	National	Guideline	Clearinghouse	search	engines.		Published	research	was	found	using	the	search	terms	“fever,”	“acute	fever,”	“pyrexia,”	“fever	control,”	“febrile	management,”	“fever	guidelines,”	“fever	treatment,”	“antipyretics,”	“antipyretic	guidelines,”	“antipyretic	therapy,”	“pediatric	fever	education,”	“pediatric	patient,”	“child,”	“infant,”	“toddler,”	“kid,”	“outpatient,”	“uncomplicated,”	“urgent	care,”	and	“outpatient	education.”		MeSH	and	MAJR	terms	included	fever,	fever/diagnosis,	and	health	education.		Articles	that	evaluated	adult	patients,	health	conditions	such	as	malaria	and	yellow	fever,	and	emergency	situations	were	excluded	in	the	search.		Filters	used	included	English,	human,	child	(birth	to	18	years),	and	published	in	the	last	5	years.		A	total	of	248	articles,	from	1981	to	2016,	were	found	and	reviewed.		The	literature	synthesis	consisted	of	36	articles,	from	2001	to	2016,	that	met	all	of	the	criteria.		There	are	a	significant	number	of	articles	that	have	been	used	in	this	review	that	are	older	than	the	desired	five	years.		This	is	because	many	of	the	significant	studies	that	are	still	relevant	today	were	done	in	the	2000’s.		There	were	no	algorithms	found	that	specifically	addressed	fever.		There	were	some	that	address	the	diagnosis	of	fever	of	unknown	origin,	but	they	were	not	applicable	to	this	project	because	this	project	does	not	focus	on	diagnosis	the	underlying	cause	of	the	fever.		The	American	Academy	of	Pediatrics	and	the	Italian	Pediatric	Society	both	have	guidelines	for	fever	and	antipyretic	treatment	of	children,	which	were	included	in	this	project’s	review	of	the	literature.	
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	 The	36	articles	were	graded	using	Mosby’s	Levels	of	Evidence.		Mosby’s	Levels	of	Evidence	(Figure	2)	has	eight	categories,	which	increase	in	strength	and	reliability	as	progression	is	made	from	the	base	to	peak	of	the	pyramid.		The	classic	pyramid	has	seven	levels;	however,	an	eighth	level	was	added.		This	level	is	named	“other”	and	includes	reviews	of	literature	and	mathematical	models.	
Figure	2.	Adjusted	Version	of	Mosby’s	Levels	of	Evidence	(Ebling	Library,	2016)	 	
Figure	3	shows	the	article	distribution	across	the	levels	of	evidence	of	the	36	articles	that	were	a	part	of	the	literature	review.		There	are	two	distinct	peaks	with	over	half	the	articles	in	level	1	and	level	6,	followed	by	those	in	levels	2,	7,	and	the	“other”	category.		Level	5	is	the	only	level	that	was	not	represented	in	this	literature	review.		Eleven	of	the	13	articles	listed	in	the	top	two	levels	focused	on	antipyretic	medication	dosing	and	comparison	among	different	medications.		The	other	studies	focused	on	parental	fever	phobia	and	fever	knowledge.			
Level 1                                                                            Meta Analysis and Systematic Reviews 
Level 2                                                                                               Randomized Control Trials 
Level 3                                                                                               Quasi-Experimental Design 
Level 4                                Case-Controlled Studies, Cohort Studies, and Longitudinal Studies 
Level 5                                                                                                         Correlational Studies 
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Figure	3.	Levels	of	Evidence	for	Articles	Critiqued	
	
Synthesis	of	Evidence	
Definition	of	Fever		The	whole	basis	of	appropriate	fever	management	is	dependent	on	the	definition	of	fever.		The	research	suggests	that	the	accepted	numerical	values	for	fever	only	have	a	slight	variation	within	the	healthcare	community,	while	there	is	a	large	variation	within	the	parent/caregiver	population.		The	evidence	indicates	a	lack	of	consistency	with	the	site	chosen	to	measure	a	fever	(e.g.,	oral,	rectal,	tympanic,	etc.),	unspecified	versus	site-specific	values,	and	an	exact	fever-defining	temperature.		
Level 1                                                                                                         9 
Level 2                                                                                                         5                                
Level 3                                                                                                         1                             
Level 4                                                                                                         1 
Level 5                                                                                                         0                                                                                     
Level 6                                                                                                       10 
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	 Unspecified	site	definitions	had	temperature	values	that	varied	between	37.5°C	and	38.0°C,	while	the	site-specific	values	were	38°C	or	38.4°C	for	rectal	and	tympanic	temperature	respectively,	37.5°C	for	oral	temperatures,	and	37.2°C	or	37.3	for	axillary	temperatures	(Carey,	2010;	Chang,	Chen,	Chang,	&	Smith,	2010;	Chiappini	et	al.,	2012;	Crook,	2010;	Gupta,	Gupta,	&	Sharma,	2007;	Hay	et	al.,	2008;	Kool	et	al.,	2013;	Martins	&	Abecasis,	2016;	McDougall	&	Harrison,	2014;	Paul,	Mayhew,	&	Mee,	2011;	Purssell	&	While,	2013;	Sarrell,	Wielunsky,	&	Cohen,	2006;	Sullivan,	&	Farrar,	2011;	Wallenstein	et	al.,	2012;	Walsh	et	al.,	2008;	Ward,	2017;	Watts,	Robertson,	&	Thomas,	2003).		The	site-specific	values	were	very	consistent	among	the	five	studies	included	in	this	review;	there	was	only	one	variation	for	two	of	the	site	locations.		The	wide	variation	in	the	unspecified	value	may	be	due	to	using	a	specific	site	without	identifying	it;	if	so,	then	the	values	may	actually	be	consistent	with	the	site-specific	values.		 The	research	shows	that	parents	and	caregivers	are	more	often	incorrect	in	their	understanding	about	the	temperature	values	for	what	defines	a	fever.		One	study	found	that	100%	of	the	parents	and	caregivers	were	incorrect,	81%	believing	a	fever	starts	when	a	temperature	reading	is	below	38°C,	and	the	other	19%	reported	that	a	fever	starts	at	a	temperature	reading	above	38.3°C	(Wallenstein	et	al.,	2012).		Another	study	found	that	only	43%	of	parents	correctly	defined	fever	as	a	temperature	at	or	above	38°C	(Martins	&	Abecasis,	2016).		Walsh	et	al.	(2007)	found	that	parents	were	fairly	consistent	in	defining	fever	at	a	level	of	37.5°C,	which	is	below	the	accepted	38°C.		None	of	the	articles	reviewed	provided	evidence	that	parents	and	caregivers	have	a	consistent	or	accurate	definition	of	fever	(Crocetti	et	
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al.,	2001;	Martins	&	Abecasis,	2016;	Wallenstein	et	al.,	2012;	Walsh	et	al.,	2007;	Walsh	et	al.,	2008).	
Dosing	One	of	the	main	focal	points	of	the	articles	is	antipyretic	dosing.		There	are	three	main	sub-topics	of	the	articles	reviewed:	antipyretic	effects	on	fever,	ibuprofen	vs.	acetaminophen,	and	monotherapy	vs.	dual	therapy.		First,	there	is	an	inconsistency	between	antipyretics	and	the	duration	of	fever.	Carey	(2010)	found	that	antipyretics	do	not	shorten	the	duration	of	fever	and,	instead,	may	actually	prolong	it.		Gupta	et	al.	(2007)	observed	that	acetaminophen	does	not	increase	the	duration	of	fever	when	compared	to	a	placebo.		Experts	and	researchers	have	concluded	that	fever	should	not	be	treated	unless	it	is	accompanied	by	discomfort	(Carey,	2010;	Chiappini	et	al.,	2016:	Crook,	2010;	Ward,	2017).	There	is	some	evidence	that	alternating/combined	therapy	may	be	more	effective	at	reducing	temperatures;	they	also	provide	better	antipyresis	at	4	and	6	hours	(Kramer	et	al.,	2008;	Paul	et	al.,	2010;	Sarrell	et	al.,	2006;	Wong	et	al.,	2013).		Dual	therapy	is	better	at	reducing	the	duration	of	fever	after	24	hours	of	treatment	when	compared	to	both	monotherapies	(Hay	et	al.,	2008).		In	contrast,	ibuprofen	was	found	to	be	equivalent	to	dual	therapy	in	terms	of	time	to	fever	clearance	and	time	without	fever	for	the	first	4	hours	after	dosing	(Hay	et	al.,	2008).		Because	there	is	limited	and	inconclusive	evidence	as	well	as	unknown	safety	concerns	about	antipyretic	monotherapy	compared	to	combination	therapy,	treatment	decisions	should	err	on	the	side	of	caution	with	the	recommendation	to	use	monotherapy	
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(Chiappini	et	al.,	2016;	Crook,	2010;	Kramer	et	al.,	2008;	Nabulsi,	2010;	Ward,	2017).	
Ibuprofen	and	Acetaminophen		The	next	subtopic	is	a	comparison	of	two	antipyretic	medications,	ibuprofen	and	acetaminophen.	It	has	been	found	that	ibuprofen	and	acetaminophen	are	both	effective	in	managing	fever	(Chiappini	et	al.,	2016;	Crook,	2010;	Purssell,	2002;	Ward,	2017)	and	both	are	well	tolerated	(Chiappini	et	al.,	2016;	Purssell,	2002;	Ward,	2017).		Ibuprofen	has	a	better	antipyretic	effect	than	acetaminophen	at	4	and	6	hours	post	dosing	(Purssell,	2002).		If	one	antipyretic	is	found	to	not	work,	than	the	alternative	medication	should	be	considered	(Crook,	2010;	Nabulsi,	2010;	Ward,	2017).			One	of	the	issues	discussed	in	many	of	the	articles	is	how	dosing	should	be	addressed,	examining	age	and	weight.		Almost	all	of	the	current	research	suggests	that	dosing	should	only	be	based	on	weight,	not	age.		However,	most	packaging	still	lists	age	and	weight	parameters.		Weight-based	dosing	(10-15mg/kg	acetaminophen	every	four	to	six	hours	and	5-10mg/kg	ibuprofen	every	six	to	eight	hours)	is	recommended	in	the	pediatric	population	for	all	pediatric	patients	(George,	Phelps,	&	Kitzmiller,	2012;	Temple,	Temple,	&	Kuffner,	2013;	Wong	et	al.,	2013).		Weight-based	dosing	needs	to	be	stressed	with	parents	when	providing	education.		This	increases	the	probability	of	correct	and	effective	dosing	when	compared	to	age	based	dosing	(Abourbih,	Gosselin,	Villenuve,	&	Kazim,	2016).		One	article	by	the	Adis	Medical	Writers	(2014)	suggests	dosing	may	be	based	on	weight	or	age.		This	is	the	
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only	evidence	found	to	suggest	age	is	an	appropriate	determinant	of	an	antipyretic	dose.	
Fever	Phobia	and	Knowledge	When	a	child	develops	a	fever,	it	may	cause	fear	in	a	parent	or	caregiver	about	the	well-being	of	the	child.		This	fear	of	potential	harm	may	cause	them	to	react,	many	times	in	inappropriate	ways.		These	decisions	may	be	based	on	incorrect	information	or	the	belief	that	a	fever	needs	to	be	completely	controlled	so	the	best	possible	outcome	for	the	child	can	occur.		Only	43%	of	parents	view	fever	as	a	temperature	above	38°C	and	their	first	line	of	defense	is	to	give	an	antipyretic	medication	(Martins	&	Abecasis,	2016).		This	results	in	medication	being	given	to	children	who	do	not	have	a	fever.		Antipyretics	should	only	be	given	in	the	presence	of	discomfort	and	there	is	no	evidence	that	the	treatment	of	fever	has	any	benefit	besides	reducing	discomfort	(Adis	Medical	Writers,	2014;	McDougall	&	Harrison,	2013;	Paul	et	al.,	2011;	Purssell,	2002;	Sullivan	and	Farrar,	2011).		Consistent	and	reliable	information	increases	parental	confidence	in	appropriate	treatment	and	helps	to	establish	proper	treatment	plans	(Anderson	et	al.,	2013;	Krantz,	2001;	Walsh	et	al.,	2007;	Walsh	et	al.,	2008).		Positive	experiences	reduce	concerns,	healthcare	visits,	and	antipyretic	use,	while	negative	experiences	result	in	increased	concerns,	patient	monitoring,	antipyretic	use,	and	healthcare	visits	(Walsh	et	al.,	2007).		Parents	are	quick	to	treat	fever	because	of	perceived	potential	harm,	including	the	false	belief	that	it	will	cause	brain	damage	or	that	antipyretics	will	help	to	prevent	febrile	seizures	(Purssell,	2008;	Wallenstein	et	al.,	2012;	Walsh	et	al.,	2008).		Two	studies	found	that	almost	90%	(e.g.	87.8%	and	89%)	of	parents	gave	an	
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antipyretic	medication	when	their	child	presented	with	what	the	parents	believed	to	be	a	fever,	with	or	without	a	numerical	value,	even	though	they	appeared	to	be	comfortable	(Wallenstein	et	al.,	2012;	Walsh	et	al.,	2008).			Fever	phobia	is	still	prevalent	in	society	(Crocetti	et	al.,	2001;	Martins	&	Abecasis,	2016;	Purssell	&	Collins,	2016).	Some	authors	note	that	parental	perspectives	about	fever	and	its	treatment	are	culturally	influenced	due	to	fever	phobia’s	consistency	and	perseverance	over	time	(Purssell	&	Collins,	2016).		Therefore,	guidelines	need	to	consider	cultural	influences	on	parent’s	knowledge,	attitudes,	and	barriers	to	following	recommended	fever	treatment	guidelines	(Edwards	et	al.,	2006).		They	also	need	to	reinforce	appropriate	measures	such	as	rest,	hydration,	and	wearing	light	clothing,	as	well	as	educate	about	physical	measures	that	are	not	helpful	such	as	sponging	down	and	the	use	of	a	direct	fan	in	an	attempt	to	cool	the	child	(Carey,	2010;	El-Radhi	&	Sahib,	2008;	Purssell,	2008;	Walsh	et	al.,	2008).	
Quality/Quantity/Consistency	of	Evidence		 The	quality	of	evidence	is	good	across	all	the	topical	aspects	of	fever;	however,	the	topic	of	antipyretic	dosing	has	the	highest	quality	of	evidence.		The	topic	of	fever	phobia	and	knowledge	has	lower	levels	of	quality,	but	this	may	be	due	to	the	nature	of	the	topic	and	the	research	used	to	gather	the	data.				 Overall,	the	quantity	of	articles	contributing	to	the	body	of	evidence	is	good.		However,	a	sizeable	amount	of	the	research	is	older,	from	between	2012	and	2000,	suggesting	that	newer	studies	may	be	helpful	to	keep	current	with	the	present	landscape.		More	data	need	to	be	gathered	for	antipyretic	dosing,	specifically	
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comparative	research	between	ibuprofen	and	acetaminophen	doses	and	impacts,	as	well	as	data	about	whether	monotherapy	or	dual	therapy	is	the	best	approach	to	treat	fever.		Evidence	is	not	as	consistent	for	dosing,	with	recommendations	noted	for	both	monotherapy	and	dual	therapy.		This	evidence	is	starting	to	trend	more	towards	supporting	dual	therapy,	but	there	are	still	gaps	in	the	research	that	prevent	some	of	the	articles	from	making	a	dual	therapy	recommendation.		 There	is	good	consistency	of	evidence	for	the	lack	of	an	appropriate	parental	definition	of	fever,	as	well	as	the	lack	of	parental	knowledge	and	the	prevalence	of	fever	phobia,	all	of	which	contributes	to	inappropriate	treatment	of	children’s	fever	by	parents.		
Weaknesses/Gaps/Limitations		 Most	of	the	studies	used	in	this	review	of	the	literature	cite	the	need	for	larger	sample	sizes,	more	heterogeneous	populations	to	allow	for	better	generalizability,	and	the	need	to	reduce	the	possibility	of	bias	in	future	research	about	fever	treatment.		Limitations	of	the	literature	review	completed	to	ascertain	the	best	evidence	include	gaps	in	information	that	prevent	a	complete	understanding	of	the	best	approach	to	treating	children	for	fevers.	Specific	gaps	in	the	research	include	how	to	effectively	decrease	fever	phobia,	the	need	for	a	more	complete	investigation	into	dosing	efficacy	of	the	different	types	of	monotherapies	as	well	as	differences	between	monotherapies	and	dual	therapies,	parental	adherence	to	dual	therapy	treatment	strategies,	any	resulting	negative	outcomes,	and	the	effects	of	antipyretics	on	child	discomfort.	
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Innovation	and	Objectives		 The	goal	of	this	project	was	to	develop	a	protocol	to	implement	appropriate	antipyretic	guidelines	to	help	improve	recognition	and	treatment	of	fever	for	pediatric	patients	aged	six	months	to	six	years	old,	including	only	patients	who	are	non-emergent	and	presenting	without	a	complicated	illness.		The	best	approach	for	this	project	was	to	develop	a	clinical	practice	guideline	(CPG),	in	the	form	of	an	algorithm	and	a	fever	facts	sheet.		The	antipyretic	algorithm	and	fever	facts	sheet	can	simplify	a	potentially	complicated	situation	involving	parents	or	caregivers	with	preconceived	ideas	of	what	fever	is	and	how	it	should	be	treated.		The	antipyretic	algorithm	can	guide,	but	not	force,	the	direction	a	health	care	team	member	will	take	with	the	parents	of	a	pediatric	patient.		A	CPG	can	help	to	establish	continuity	of	care	among	health	care	team	members	about	the	treatment	of	fever	from	the	initial	encounter	with	the	child	through	the	duration	of	the	child’s	illness,	including	fluctuations	in	fever	measurements.		It	will	also	allow	for	clinicians’	independence	and	variation	within	the	algorithm,	depending	on	each	specific	situation.			The	evidence-based	recommendations	focus	on	optimizing	and	streamlining	care,	while	minimizing	patient	exposure	to	inappropriate	or	unnecessary	therapies.		Within	the	algorithm,	there	are	appropriate	education	cues	and	steps	to	help	the	health	care	team	in	the	clinic	and	the	parent	or	caregiver	in	the	home	setting.	Two	innovations	have	been	made	for	this	project,	an	algorithm	for	health	care	team	members	(see	appendix	A)	and	a	fever	handout	for	parents	and	caregivers	(see	appendix	B).		Both	are	based	on	the	evidence	gathered	during	the	literature	review	and	synthesis;	the	American	Academy	of	Pediatrics	and	Italian	
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Pediatric	Society	guidelines	are	used	as	the	foundation	for	both	innovations.		The	health	care	team	members’	treatment	algorithm	provides	recommendations	on	how	to	address	fever	or	perceived	fever	with	pharmacologic	and	non-pharmacologic	techniques.		The	patient	fever	education	handout	provides	some	clarity	on	what	fever	is,	evidence-based	therapies,	and	clarification	on	some	misconceptions	about	fever.		The	content	for	both	the	algorithm	and	handout	are	supported	by	the	evidence-based	research	and	fever	treatment	recommendations	identified	as	a	result	of	the	literature	review.		
Summary		 Pediatric	fever	is	a	common	complaint	seen	in	the	outpatient	clinical	setting.		This	chapter	discussed	the	need	for	parental	and	caregiver	education	focused	on	alleviating	parental	fear	about	fever,	discrepancies	in	provider	and	parents’	knowledge	about	the	definition	and	measurement	of	fever,	and	recommended	antipyretic	treatment	guidelines.		This	DNP	project	is	proposing	the	use	of	an	antipyretic	guideline	and	fever	facts	sheet	for	health	care	team	members	and	parents	to	address	these	issues.		The	goal	is	to	properly	recognize	and	manage	fever	as	well	as	educate	parents	about	fever,	appropriate	fever	therapies,	and	incorrect	beliefs	concerning	fever.	
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Chapter	3:	Methods		 This	chapter	discusses	the	methods	of	the	DNP	project,	and	explains	how	the	evidence-based	practice	change	was	implemented	and	evaluated	in	the	clinical	setting.		The	ACE	Star	Model	of	Knowledge	Transformation	was	also	used	to	facilitate	the	implementation	process.		The	content	of	this	chapter	describes	the	practice	integration	and	process	outcomes	evaluation	steps.		The	focus	of	these	two	steps	was	to	assimilate	the	practice	changes	and	then	evaluate	their	effectiveness	on	the	target	populations.		This	was	done	by	first	assessing	the	current	practice	at	the	clinic	and	identifying	stakeholders,	followed	by	developing	the	intervention	and	implementation	plan,	and,	subsequently,	analyzing	data	collected	to	evaluate	the	intervention.		Finally,	the	resources,	dissemination	plan,	human	subject	considerations,	and	limitations	will	be	addressed.			
PICO	and	Clinical	Question	
	 The	purpose	of	the	DNP	project	was	to	answer	a	clinical	question;	in	order	to	do	this	a	PICO	grid	and	clinical	question	were	constructed.		Figure	4	displays	the	PICO	grid	which	was	used	to	construct	the	clinical	question:		Will	an	antipyretic	guideline	and	fever	facts	sheet	help	to	improve	recognition	and	treatment	of	fever	in	the	non-emergent	febrile	pediatric	patient,	aged	six	months	to	six	years,	without	a	complicated	illness,	in	an	urgent	care	setting,	when	compared	to	the	current	practice?			
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Figure	4.	PICO	Grid	P	 The	non-emergent	febrile	pediatric	patient,	aged	6	months	to	6	years,	and	without	complicated	illness,	in	an	urgent	care	setting	I	 1.	Antipyretic	guideline	for	the	health	care	team	2.	Fever	facts	sheet	for	parents/caregivers	C	 Decision-making,	concerning	the	febrile	pediatric	patient,	without	the	use	of	a	protocol	or	guideline	to	address	the	project	outcomes	O	 Improved	recognition	and	appropriate	treatment	of	fever	in	the	clinic	and	home	settings				
EBP	Implementation	Plan	
Overview			This	evidence-based	practice	(EBP)	project	implemented	the	innovations	with	the	help	of	the	health	care	team	at	UCWM.		Including	the	health	care	team	members	in	the	development	and	implementation	of	the	project	was	an	important	factor	in	the	success	of	the	project.		Understanding	and	aligning	the	goals	of	the	team	members	with	the	goals	of	the	project	was	key	during	the	implementation	stage.		Once	this	had	been	done,	the	team	could	work	together	to	implement	the	practice	change	and	achieve	the	desired	outcomes.	
The	Practice	Change			The	goals	of	this	project	were	to	develop	a	clinical	protocol	for	qualifying	pediatric	patients	as	well	as	to	provide	consistent	evidence-based	education	to	parents	and	caregivers	of	the	qualifying	pediatric	patients.		This	was	done	by	following	an	antipyretic	guideline	(see	appendix	A)	and	fever	facts	sheet	(See	appendix	B),	which	were	focused	on	closing	the	protocol	gaps	in	the	current	practice.	
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Characteristics	of	the	Innovation			 Some	of	the	biggest	concerns	for	the	implementation	of	an	innovation	were	going	to	be	adoption	success	and	the	likelihood	of	sustainability.		To	measure	this,	Rogers	(2003)	discusses	that	one	can	look	at	the	characteristics	of	the	innovation,	which	are	relative	advantage,	compatibility,	complexity,	trialability,	and	observability.			 Relative	advantage,	when	comparing	to	the	current	practice,	was	an	obvious	strength.		This	is	because	there	was	no	current	guideline	that	was	used	in	the	clinic;	the	members	of	the	health	care	team	individually	made	decisions	concerning	pediatric	fever	treatment.		The	current	practice	allowed	for	increased	variation,	decreased	consistency,	and	the	need	for	multiple	interactions	between	health	care	team	members	to	meet	the	needs	of	the	patient,	which	may	have	reduce	parental	confidence	in	the	providers	and	health	care	team.		This	decrease	in	confidence	may	have	increased	discussion	times,	call	backs,	and	follow	up	visits	(Walsh	et	al.,	2007).		A	protocol	allowed	for	consistency	in	the	approach	to	antipyretic	therapy	for	children	and	also	allowed	the	nurse	to	complete	some	tasks	independently,	which	helped	alleviate	parental	concerns.		 Compatibility	was	also	considered	a	strength	because	it	aligned	with	the	clinic’s	value	on	evidence-based	practice	as	well	as	the	desire	to	increase	efficiency	and	productivity.		Developing	a	protocol,	using	EBP,	helped	to	address	the	many	different	patient	and	parental	concerns.		The	facility’s	population	is	multicultural,	making	it	even	more	important	to	use	the	most	reliable	and	up	to	date	research.	This	helps	to	be	consistent	when	faced	with	such	variance	in	education,	knowledge,	
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and	cultural	perspectives	about	illness	and	fever.		The	better	the	guideline,	the	better	the	clinic	was	prepared	to	deal	with	the	dynamic	needs	of	the	patient	and	parents.		 Complexity	was	a	strength	of	the	innovation	in	that	it	is	simple	and	straightforward.		One	of	the	keys	to	adoption	was	the	need	for	materials	that	can	be	easily	interpreted	and	assimilated	into	practice;	the	algorithm	and	fever	facts	sheet	were	just	that.		Fever	needed	to	be	recognized	and	treated	quickly	so	the	focus	of	the	visit	would	be	on	the	source	of	the	fever.		The	innovations	were	easy	to	use	and	they	also	helped	decrease	distraction,	making	the	whole	process	less	confusing	and	complex.		 Trialability,	or	the	ease	of	running	a	trial/pilot	study,	was	also	a	strength.		Implementing	the	guideline	was	essentially	an	adjustment	in	the	health	care	treatment	steps	and	a	modification	of	the	education	given.		This	could	be	tried	on	a	small	scale	and	adjusted	as	needed,	thereby	supporting	trialability.				 Observability	was	the	one	characteristic	that	could	have	been	considered	a	strength	and	weakness,	depending	on	which	outcomes	were	being	considered.		The	antipyretic	algorithm	guideline	was	observable,	and	the	short-term	outcomes	were	directly	seen	in	the	clinic.		However,	the	long-term	effects	on	changes	in	parental	knowledge	and	treatment	choices	were	difficult	to	observe	due	to	the	characteristics	of	the	urgent	care	setting.		The	impact	that	the	fever	facts	sheet	had	was	also	more	difficult	to	observe	because	of	its	long-term	focus.		There	was	no	long-term	follow	up	with	patients,	considering	that	many	were	on	vacation	and	
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were	only	on	the	island	for	a	matter	of	days.		Because	of	this,	the	focus	needed	to	be	more	on	the	short-term	outcomes	than	the	long-term	ones.		 Long-term	observability	was	the	only	characteristic	that	was	of	concern	with	the	project.		However,	all	other	characteristics	of	innovation	provided	strength	during	the	implementation	of	the	project	as	well	as	in	sustaining	the	innovation.		When	looking	back	at	the	characteristics	of	innovation,	it	appears	that	this	project	had	a	good	likelihood	of	adoption	and	sustainability.	
Roles	during	Innovation	Process			
	 It	was	critical	to	obtain	an	understanding	of	the	roles	that	were	part	of	the	innovation	implementation	process	and	who	filled	them.		Understanding	who	and	what	the	assets	were	helped	to	better	facilitate	change.		The	key	roles	during	the	change	project	were	the	change	agents,	the	change	champion,	and	the	opinion	leader	(Rogers,	2003).		All	three	of	these	roles	helped	to	inspire	the	adoption	of	change	within	the	clinic	and	with	the	users	of	the	innovation.				 Change	agent/opinion	leader.		UCWM	is	a	small	clinical	setting,	which	means	some	of	these	roles	overlapped.		The	change	agent/opinion	leader	was	the	medical	director,	who	also	owns	this	facility.		Her	role	as	doctor/owner	gave	her	exceptional	power	and	influence	over	the	culture	of	the	clinic,	making	her	a	valuable	source	of	knowledge	and	influence	during	the	implementation	process.		 Change	agent.		The	DNP	student	was	also	a	change	agent	during	the	process	because	of	his	lead	role	as	well	as	being	the	individual	who	brought	the	change	innovation	to	the	clinic.		His	knowledge	of	the	subject	matter	was	used	as	a	resource	throughout	the	process.	
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	 Change	champion.		The	change	champion	was	the	physician	assistant,	who	had	an	active	role	as	a	decision	maker	for	the	healthcare	process	at	the	clinic	as	well	as	being	an	influence	on	other	members	of	the	team.		This	active	role	was	translated	into	being	a	key	player	during	the	implementation	process.					 Other.		The	nurses	on	the	health	care	team	and	the	parents	of	the	pediatric	patients	were	considered	the	users.		They	adopted	the	innovation	and	applied	it	in	the	clinical	setting.		The	adoption	rate	of	the	users	helped	determine	the	success	of	the	project.		The	ability	of	the	change	agents,	change	champion,	and	opinion	leader	to	transform	the	clinical	culture	and	the	opinions	of	the	users	was	key	to	facilitating	this	change.	
Adopter	Categories		
	 	The	adoption	process	had	a	ripple	effect	that	started	with	one	group	and	then	moved	on	to	the	next.		These	groups	were	determined	by	their	opinion	of	the	innovation	as	well	as	by	the	process	itself.		Rogers	(2003)	discusses	that	there	are	five	categories	of	adopters:	the	innovators,	early	adopters,	early	majority,	late	majority,	and	laggards.		The	innovators	were	those	who	create	the	innovation	and	were	responsible	for	initiating	the	implementation.		The	early	adopters	were	those	who	integrated	the	innovation	early;	they	also	were	well	connected	within	the	facility’s	social	network	and	commanded	respect	from	the	others.		The	early	majority	were	those	who	adopted	the	new	ideas	after	some	deliberation;	they	were	people	who	were	connected	to	the	social	system	of	the	facility	but	did	not	hold	positions	of	power	or	leadership.		The	late	majority	were	those	who	could	be	skeptical	to	new	ideas,	therefore	they	needed	to	be	convinced	and	assured	about	the	
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innovation’s	effectiveness.		This	group	needed	discussions,	proof,	and	understanding	of	why	the	change	was	important;	once	their	views	were	aligned	to	the	new	ideas	they	were	more	willing	to	adopt.		The	last	group	was	the	laggards;	they	were	the	people	rooted	in	traditional	beliefs	and	had	a	hard	time	adjusting	to	a	new	way	of	thinking.		This	group	required	the	most	dialogue	and	evidence-based	information	to	change	their	way	of	thinking.		They	required	multiple	discussions	from	multiple	sources	to	truly	buy	in	to	a	new	idea,	which	provided	the	biggest	challenge	due	to	the	nature	of	the	urgent	care	visit.		This	group	did	not	completely	adopt	the	innovations	during	their	exposure	to	the	facility	and	project;	rather	this	exposure	initiated	the	change	process	for	them	(Rogers,	2003).		 The	small	clinical	setting	resulted	in	a	close-knit	culture	and	natural	unity	when	it	came	to	innovation	and	change.		Adoption	tended	to	happen	quickly	or	not	at	all,	depending	on	the	acceptance	of	the	innovation.		The	innovator	was	the	DNP	student	since	he	developed	the	innovation	and	led	the	implementation	project.		He	also	had	a	unique	situation	because	he	held	the	position	of	lead	registered	nurse	at	the	clinic;	therefore	he	assumed	multiple	roles	throughout	the	implementation	process.		 The	medical	director,	the	physician	assistant,	and	the	front	desk	manager	were	the	early	adopters.		Their	positions	(doctor/owner,	physician’s	assistant,	and	front	desk	manager)	resulted	in	their	having	respect	and	power.		These	three	individuals	were	looked	upon	when	decisions	needed	to	be	made	and	questions	about	protocols	arose.		They	were	integral	in	the	operations	of	the	clinic	and	key	to	adoption	of	the	new	innovations.			
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	 The	early	majority	included	the	health	care	team	nurses.		They	were	a	part	of	the	system	and	culture,	but	they	did	not	hold	leadership	roles.		They	adopted	the	innovations	and	then	used	them	during	implementation	and	as	instruction	for	the	parents/caregivers.		Their	adoption	and	use	of	the	new	guideline	was	key	in	facilitating	the	adoption	in	the	next	two	groups.			 The	last	two	groups	were	the	late	majority	and	laggards,	which	were	comprised	of	the	parents/caregivers	of	the	pediatric	patients.		The	parents/caregivers	were	broken	into	the	two	groups	depending	on	how	quickly	they	bought	into	the	new	guideline	and	fever	facts	sheet.		Parents	were	different	depending	on	their	underlying	knowledge	and	beliefs	about	fever.		They	were	skeptical	of	the	change,	which	made	them	members	of	the	late	majority,	or	they	were	hesitant	due	to	traditional	values,	which	made	them	members	of	the	laggards	(Rogers,	2003).		Implementation	of	the	innovation	ended	with	these	two	groups	and	was	not	considered	a	success	until	there	was	a	high	adoption	rate	within	them.		The	process	of	adoption	began	with	the	innovator,	progressed	from	one	category	to	the	next,	and	ended	with	the	adoption	of	the	laggards.	
Social	Systems		
	 	Identify	the	health	care	organization.		The	UCWM	is	an	urgent	care	clinic	focused	on	providing	competent	and	high	quality	healthcare	services	with	self-determined,	five-star,	customer	service.		This	is	an	authoritarian	style	system	where	the	doctor/owner	is	in	charge	of	the	decision-making	process	or	has	the	final	say	in	all	matters.		There	is	a	focus	on	evidence-based	research	and	change	when	deemed	
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appropriate.		The	internal	characteristics	of	the	organization	are	its	centralized	power,	interconnected	communication	structure,	and	small	size.				 There	are	typically	ten	employees	who	staff	the	UCWM,	which	lends	itself	to	direct	lines	of	communication	among	all	employees.		The	medical	director	is	at	the	top	of	the	hierarchy,	with	the	lead	RN,	front	desk	manager,	and	full-time	physician	assistant	at	the	next	level.		The	bottom	tier	of	the	hierarchy	consists	of	the	other	staff	nurses,	medical	assistants,	and	front	desk	employees.	
	 Identify	the	practice	setting.	The	setting	for	this	project	was	UCWM	on	Maui.		It	is	strategically	located	near	the	major	resorts	and	condominiums	in	Wailea	on	the	south	side	of	Maui.		There	are	no	units	within	the	clinic,	however	the	clinic	can	be	divided	into	two	subgroups:	the	waiting	room	or	front	office,	and	the	patient	care	rooms.		The	practice	setting	would	specifically	include	the	patient	care	rooms	and	employees	who	deliver	direct	patient	care.		The	practice	setting	structure	is	exactly	the	same	as	structure	of	the	health	care	organization	as	a	whole;	it	is	authoritarian,	with	the	same	internal	and	individual	characteristics.	
Sample	
	 Sample	size.		This	acute	care	clinic	primarily	serves	the	tourists	who	visit	Maui	as	well	as	some	local	residents.		These	patients	include	all	ages	as	well	as	all	spectrums	of	needs	and	stability.		Most	patients	are	from	the	United	States	and	Canada;	however	there	is	representation	from	many	countries	worldwide,	including	Japan,	Australia,	England,	Germany,	and	France.		This	project	focused	on	the	pediatric	population	that	visits	the	clinic.			There	are	about	100	pediatric	patients	
AN	ANTIPYRETIC	GUIDELINE	FOR	PEDIATRIC	PATIENTS		
 33 
who	present	at	the	clinic	on	a	monthly	basis,	including	about	20	to	25	who	qualify	for	this	project.	
Inclusion/exclusion	criteria.		There	were	inclusion/exclusion	criteria	for	the	patients	as	well	as	the	health	care	employees	for	the	project.		The	inclusion	criteria	for	the	patients	were:	
• Presentation	with	an	acute	uncomplicated	illness/issue	
• Presentation	with	an	uncomplicated	illness/issue	
• Representation	of	an	age	between	six	months	and	six	years	
• Presentation	at	UCWM	during	the	months	of	July	2017	through	October	2017	
• Having	interaction	only	with	health	care	team	members	who	have	been	trained	on	the	guideline	and	fever	facts	sheet		
• English	speaking	parents		The	exclusion	criteria	for	the	patients	were:	
• Presentation	with	a	chronic	illness/issue	
• Presentation	with	a	complicated	acute	illness/issue	
• Representation	of	an	age	younger	than	six	months	or	older	than	six	years	
• Presentation	at	UCWM	before	July	2017	or	after	October	2017	
• Receiving	treatment	from	an	employee	who	had	not	yet	been	trained	on	the	guideline	and	fever	facts	sheet	
• Parents	did	not	speak	English	The	inclusion	criteria	for	the	health	care	employees	were:		
• Being	employed	at	UCWM	anytime	during	the	months	of	July	2017	through	October	2017	
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• Being	trained	on	the	innovation	guideline	and	fever	facts	sheet	prior	to	interaction	with	included	patients			The	exclusion	criteria	for	the	health	care	team	were:		
• Not	employed	at	UCWM	during	the	months	of	July	2017	through	October	2017		
• Not	trained	on	the	guideline	and	fever	facts	sheet	training	prior	to	qualified	patient	interaction			 The	end	goal	of	this	project	was	to	create	seamless	continuity	of	care	to	address	the	febrile	pediatric	patient,	which	continued	with	the	parents	indefinitely	after	their	urgent	care	visit.		This	was	a	two-part	goal,	one	focused	on	the	members	of	the	health	care	team	and	the	other	on	the	parents	and	caregivers	of	the	target	population.	
Stakeholder	Engagement	Plan			Stakeholder	engagement	and	buy	in	was	the	first	step	towards	minimizing	implementation	issues.		Matching	the	right	employees	for	the	right	tasks,	based	on	the	program	standards,	was	an	important	factor	for	stakeholder	engagement.		Understanding	the	key	contributing	factors	for	implementation	helped	to	identify	the	stakeholders	and	a	hierarchy	for	the	project.		The	more	factors	a	stakeholder	influences,	the	more	valuable	they	became.		As	seen	in	Table	1,	the	key	contributing	factors	for	the	engagement	plan	were	to	increase	credibility,	help	with	design,	implement	interventions,	advocate	for	implementation,	and	authorize	or	fund	the	implementation	changes.		The	medical	director	is	at	the	top	of	the	hierarchy;	she	influences	all	contributing	factors	and	was	the	key	stakeholder	for	success.		She	had	
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played	an	integral	part	in	choosing	the	topic,	identifying	triggers	and	outcomes,	and	supporting	the	development	of	the	project.			The	physician	assistant	is	the	next	level	in	the	hierarchy;	she	influenced	all	contributing	factors	except	for	authorizing	and	funding	the	implementation	changes.		She	influenced	the	development	of	the	antipyretic	algorithm	and	fever	facts	sheet	as	well	as	helped	to	define	the	data	points	that	were	tracked.			The	front	desk	manager	makes	up	the	next	level	of	the	hierarchy;	she	helped	to	increase	credibility,	helped	with	design	adjustments,	and	advocated	for	implementation.		Her	role	was	influential	to	the	project	once	implementation	began	because	of	her	position	and	unique	perspective	on	the	patients	and	their	parents/caregivers.			As	stated	previously,	these	three	stakeholders	also	held	positions	of	power	within	the	company	and	are	looked	to	for	direction	and	advice.		Their	positions	of	power	and	influence	on	contributing	factors	made	them	the	key	stakeholders	for	this	change	project.			The	staff	nurses	make	up	the	rest	of	the	stakeholders.		They	were	integral	to	this	project	because	of	their	direct	contact	with	the	patients	and	their	parents/caregivers.		They	were	key	players	in	implementation	and	data	collection,	as	well	as	sources	of	information	for	feedback	and	suggestions	for	modification.						
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Table	1		
Stakeholders	and	the	Key	Contributing	Factors		 Increasing	credibility	 Helping	with	design	 Implementation	of	interventions	 Advocating	for	implementation	 Authorizing/funding	the	implementation	changes		The	medical	director	
	X	 	X	 	X	 	X	 	X	
	The	DNP	student	 	X	 	X	 	X	 	X	 		The	physician	assistant		
	X	 	X	 	X	 	X	 	
	The	front	desk	manager	
	X	 		 	 	X	 	
	Staff	Nurses	 	X	 	 	X	 	X	 			 The	stakeholders	were	an	integral	part	of	implementation	as	well	as	the	evaluation	plan.		Focusing	on	aligning	the	content	expertise,	motivation,	and	interests	of	the	stakeholders	to	the	innovations	in	the	change	project	helped	to	increase	success	during	implementation	and	maximized	sustainability.	
Application	of	Communication	Processes			When	implementing	a	change	project,	there	needs	to	be	strong	lines	of	communication	established	in	order	to	maximize	the	chances	of	success.		These	channels	need	to	start	early	and	stay	open	past	the	implementation	phase.		Once	the	innovation	has	been	established	the	next	goal	is	sustainability,	which	will	also	rely	on	these	established	lines	of	communications.			
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	 At	UCWM	the	medical	director,	physician	assistant,	and	front	desk	manager	were	the	key	stakeholders	and	early	adopters	for	this	project.		The	nurses	represented	the	early	and	late	majority	as	well	as	the	rest	of	the	stakeholders	within	the	clinic.		Initially,	communication	between	the	DNP	student	and	the	three	key	stakeholders	was	direct,	including	one-on-one	informal	meetings	as	well	as	group	discussions,	depending	on	what	was	needed.		These	meetings	were	to	discuss	ideas,	align	the	stakeholders,	and	map	out	the	implementation	process.		Once	implementation	began,	there	were	informal	meetings	and	discussions	when	required.		The	fever	facts	sheet	handouts	were	displayed	in	the	pediatric	exam	room.		The	pediatric	antipyretic	algorithm	was	posted	in	the	clinic’s	laboratory	and	the	pediatric	exam	room.		This	paperwork	doubled	as	flyers	and	promotional	material	for	the	project	itself	and	contained	educational	material	to	help	answer	questions.		 Educational	sessions	were	initiated	on	a	one	on	one	basis	or	in	small	groups,	which	provided	preparation	for	implementation	and	updated	changes	to	the	parental/caregiver	education	plan	during	implementation.		They	were	informal	meetings	and	continued	as	needed,	depending	on	the	situation	or	needs	of	the	staff.	
Evaluation	Plan	An	evaluation	plan	was	developed	to	structure	the	DNP	project,	and	it	became	the	framework	to	assess	the	success	of	the	innovations.		This	plan	was	based	on	an	evaluation	question,	which	provided	the	parameters	for	the	plan.
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Evaluation	Question			Will	an	antipyretic	guideline	and	fever	facts	sheet	help	the	health	care	team	and	parents/caregivers	meet	the	95%	success	goal	for	appropriate	recognition	and	treatment	of	fever	in	non-emergent	febrile	pediatric	patients,	aged	six	months	to	six	years	without	complicated	illness,	in	an	urgent	care	setting,	over	a	four	month	period?		 The	plan	took	the	parameters	of	the	question	and	turned	them	into	a	blueprint	for	how	the	project	was	be	conducted.		For	the	project	to	be	successful,	the	design	of	the	plan	needed	to	have	integrity.			
Integrity	of	Evaluation	Design				 The	evaluation	plan	for	this	project	used	the	CDC	Evaluation	Plan	Framework’s	program	standards	to	maximize	adaptation,	sustainability,	and	integrity	of	the	design	(Milstein,	Wetterhall,	&	The	CDC	Evaluation	Working	Group,	2000).		The	CDC	program	standards	support	integrity	in	an	evaluation	by	giving	focus	and	balance	to	the	direction	of	the	evaluation.	They	accomplish	this	by	providing	the	user	with	four	categories	on	which	to	base	decisions:	utility,	feasibility,	propriety,	and	accuracy	(Milstein	et	al.,	2000).				 Utility.		This	evaluation	plan	has	utility	because	the	results	were	relevant	and	valid	for	all	members	of	the	health	care	team	as	well	as	the	parents	and	caregivers	of	the	pediatric	patients.		The	new	protocol	allowed	the	nurses	to	appropriately	and	independently	address	pediatric	fever,	which	gave	the	providers	more	time	to	focus	on	underlying	causes	without	interruption.		They	also	helped	to	appropriately	guide	the	parents’	and	caregivers’	choices	for	home-based	treatments.		
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This	information	was	gathered,	analyzed,	and	interpreted	in	a	timely	manner,	ensuring	adequate	feedback	to	make	future	decisions	about	treatments.		 Feasibility.		This	evaluation	plan	also	demonstrates	feasibility	because	the	planned	activities	were	realistic	with	consideration	for	time,	resources,	and	available	expertise.		This	plan	easily	integrated	into	the	facility’s	established	protocols,	decreasing	the	need	for	extra	resources.		Even	when	factoring	in	unforeseen	complications,	the	need	for	facility	resources	was	relatively	minor.		 Propriety.		The	plan	addressed	the	rights	and	protected	the	welfare	of	the	individuals	involved.		No	party	involved	was	forced	into	a	treatment;	informed	decisions	were	made	after	appropriate	education	had	taken	place.		The	plan	engaged	all	parties	affected	by	the	innovations,	including	the	health	care	team	and	parents/caregivers	of	the	qualifying	patients.		The	focus	of	this	project	was	to	guide	the	use	of	antipyretic	medications,	which	resulted	in	more	appropriate	use.		This	objective	is	rooted	in	advocacy	for	the	patients	and	focused	on	protection	of	their	rights	as	individuals/families.		 Accuracy.		The	findings	were	based	upon	data	taken	directly	from	the	charts	of	the	qualifying	patients.		The	antipyretic	guideline	was	followed	for	each	qualifying	patient;	this	helped	to	provide	valid,	consistent,	and	accurate	results.		A	copy	of	the	guideline	was	placed	in	the	chart	of	every	qualifying	patient	for	future	review	if	there	were	any	questions.	The	information	provided	a	valid	interpretation	of	the	innovations	based	on	the	outcome	data.		The	plan	established	a	continuity	of	care	that	was	backed	by	accurate	documentation,	which	provided	a	foundation	of	confidence	to	continue	appropriate	treatments.			
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	 The	integrity	of	design	for	this	project	was	based	on	the	CDC’s	Evaluation	Plan	Framework	(Milstein	et	al.,	2000).		The	framework	helped	to	evaluate	the	environment,	align	the	contributing	parties,	and	provide	accurate	and	valid	findings.		Balancing	the	utility,	feasibility,	propriety,	and	accuracy	of	the	evaluation	plan	maximized	this	integrity.		All	four	categories	were	utilized,	establishing	integrity	for	this	project’s	design.	
Program	Description	UCWM	treats	about	100	pediatric	patients	a	month,	including	20	to	25	patients	who	qualified	for	this	project.		There	was	no	written	protocol	to	address	how	to	determine	fever	and	when	antipyretic	treatments	should	be	used.		There	is	an	established	antipyretic	administration	guideline,	which	outlines	appropriate	antipyretic	dosing,	but	it	does	not	outline	when	to	use	them.		The	guideline	does	not	define	fever	or	explain	the	need	for	the	presence	of	discomfort	in	order	to	appropriately	treat	with	antipyretics.		This	project	was	focused	on	filling	the	gap	in	protocol	to	prevent	error	and	establish	consistent	evidence-based	care	for	patient	safety.			Fever	education	for	the	parents	and	caregivers	is	provided	by	the	health	care	team	and	can	vary	from	one	member	to	the	next.		There	was	no	required	teaching	material	and	all	information	was	given	orally.		This	project	also	focused	on	developing	an	improved	structured	protocol	for	patient	education	concerning	the	febrile	pediatric	patient.	
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Current	Practice			Previously,	when	a	pediatric	patient	presented	in	the	clinic,	fever	recognition	was	the	responsibility	of	the	nurse	and	the	provider	who	determined	treatment.		The	nurse	would	take	the	temperature	and	obtain	a	brief	history	of	the	chief	complaint	and	symptoms	during	the	intake	period.		The	nurse	reported	to	the	provider,	who	would	then	begin	her	exam	and	assessment.		Once	completed,	the	provider	told	the	nurse	what	the	treatment	plan	was	and	what	the	specific	orders	were.		The	nurse	then	carried	out	the	orders	and	discharged	the	patient.		The	provider	may	or	may	not	have	interacted	with	the	patient	again,	depending	on	the	diagnoses	and	status	of	the	child.		During	the	initial	report,	the	nurse	would	discuss	the	presence	of	fever,	discomfort,	and	history	of	antipyretic	use	to	the	provider.		At	this	time,	the	provider	would	give	antipyretic	orders	or	see	the	patient	and	then	make	a	decision	about	orders.	This	situation	worked	when	the	nurse	properly	identified	fever,	notified	the	provider,	and	a	treatment	would	be	chosen.		If	communication	broke	down	or	any	of	the	decisions	were	made	based	on	incorrect	knowledge,	the	appropriate	treatment	may	not	have	been	made.		There	are	three	types	of	thermometers	available	in	the	pediatric	exam	room,	and	it	is	not	commonly	noted	on	the	chart	which	one	is	used.		During	busy	times,	identification	of	fever	does	not	always	happen,	or	antipyretic	orders	are	not	carried	out	due	to	this	being	a	low	priority	status	in	a	busy	urgent	care	clinic.			Previously,	a	discussion	about	fever	and	the	treatment	of	fever	only	occurred	when	questions	were	asked	by	the	parent/caregiver.		There	was	nothing	in	the	
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clinic	to	help	initiate	a	conversation	about	fever	or	provide	evidence-based	information.		When	a	discussion	was	triggered,	that	member	of	the	health	care	team	determined	what	information	should	be	provided.		There	was	no	education	guideline	to	establish	consistency	or	validate	the	information	being	provided.	
How	the	EBP	Changes	the	Program			The	antipyretic	guideline	(see	appendix	A)	provides	a	protocol	to	address	the	definition	of	fever,	establishes	the	criteria	needed	for	the	use	of	an	antipyretic,	and	provides	alternative	treatments.	During	the	initial	intake,	the	nurse	follows	the	guideline	for	every	qualifying	patient.		This	removes	the	need	to	interact	with	the	provider	and	wait	for	an	antipyretic	treatment	plan.		Instead	of	needing	multiple	interactions	to	carry	out	an	antipyretic	order,	the	guideline	provides	a	standing	protocol	and	orders.		A	copy	of	the	guideline,	marked	by	the	nurse,	is	a	part	of	the	patient’s	chart	in	case	there	are	questions	about	any	decisions	made.	The	fever	facts	sheet	(see	appendix	B)	provides	appropriate	treatment	information	to	the	parents	and	caregivers	as	well	as	helps	to	initiate	conversation	about	pediatric	fever.		Once	a	dialogue	has	been	initiated,	the	facts	sheet	provides	an	evidence-based	educational	guideline	the	discussion	can	follow.		This	provides	educational	consistency	and	assures	a	foundation	of	evidence-based	information.		Within	48	hours,	the	DNP	student	called	the	parents	or	caregivers	to	follow	up	on	the	child’s	fever,	the	parent/caregiver’s	treatment	of	the	fever,	and	the	value	of	the	education	done	in	the	clinic	pertaining	to	fever	and	the	fever	facts	sheet.	
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How	the	EBP	Improves	Current	Practice			The	antipyretic	guideline	(see	appendix	A)	and	fever	facts	sheet	(see	appendix	B)	allow	for	the	nurses	to	address	pediatric	fever	without	consulting	the	provider,	and	establishes	consistent	evidence-based	education	the	parents	can	easily	follow.		Providers	were	able	to	spend	their	time	on	the	underlying	issues,	without	having	to	address	the	concerns	about	fever.		This	seamless	care	helped	to	establish	confidence	with	the	parents,	improving	their	adherence	to	the	EBP,	and	increased	appropriate	recognition	and	treatment	of	fever	in	the	clinic	and	at	home.	
Definitions	The	variables	of	implementation	need	to	be	defined	in	order	to	allow	for	an	understanding	about	the	evaluation.		This	includes	the	project	interventions,	outcomes,	comparisons,	and	sample.			The	evaluation	section	of	the	project	uses	a	comparison	of	health	records	for	an	impact	evaluation	of	an	antipyretic	guideline	and	a	fever	facts	sheet.		The	evaluation’s	findings	comment	about	how	these	innovations	impact	appropriate	recognition	and	treatment	of	fever	for	the	pediatric	patient	in	an	urgent	care	setting	as	well	as	how	effectively	parents	or	caregivers	understood	the	evidence-based	approach	to	fever	and	utilized	the	appropriate	treatments.		Success	of	this	project	depended	on	the	impact	the	innovations	had	on	the	outcome	variables.			 The	evaluation	design	is	based	on	a	pre-implementation	–	post-implementation	data	analysis.		There	were	two	trend	comparisons,	one	to	evaluate	the	antipyretic	guideline	and	one	to	evaluate	the	fever	facts	sheet.		The	antipyretic	
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guideline	analysis	compares	monthly	outcomes	to	previous	years	and	the	fever	facts	sheet	analysis	compares	monthly	responses	after	implementation.	
Baseline		The	baseline	data	(T-11	and	T-12)	were	collected	from	all	qualifying	pediatric	patients	who	were	seen	from	the	months	of	July	through	October	in	2015	and	2016.		This	provides	a	snapshot	of	how	the	clinic	and	parents	addressed	the	outcome	measures	before	implementation	of	the	innovation.		
Outcome			There	are	two	outcomes	for	this	change	project,	the	first	is	the	health	care	team’s	ability	to	appropriately	recognize	and	treat	pediatric	fever,	and	the	second	is	parental/caregiver	fever	guideline	compliance.		The	first	outcome	can	be	broken	into	two	parts:	appropriate	recognition	of	fever	and	appropriate	treatment	of	fever.		The	first	part,	appropriate	recognition	of	fever,	is	defined	as	documentation	of	a	tympanic	temperature	equal	to	or	above	100.4°	F.		The	second	part,	appropriate	treatment	of	a	fever,	is	defined	as	the	use	of	an	antipyretic	medication	in	the	presence	of	fever	only	when	accompanied	by	signs	of	discomfort.		There	must	also	have	been	an	appropriate	length	of	time	since	the	last	dose	of	antipyretic	medication,	six	hours	for	ibuprofen	and	four	hours	for	acetaminophen.				 The	second	variable	is	parental/caregiver	fever	guideline	compliance,	which	is	defined	as	the	report	of	a	parent	or	caregiver	administering	an	antipyretic	medication	only	in	the	presence	of	fever	and	discomfort.		A	dose	of	ibuprofen	must	have	been	administered	at	least	six	hours	after	the	last	dose;	acetaminophen	must	be	administered	four	hours	later.		The	follow	up	call	must	be	within	48	hours	of	the	visit.	
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Intervention			There	were	two	interventions	used	during	the	change	project:	the	antipyretic	guideline	and	the	fever	facts	sheet.		The	first	intervention	is	an	antipyretic	guideline	(see	appendix	A),	which	is	an	algorithm	designed	to	guide	the	health	care	team	members	through	appropriate	recognition	and	treatment	of	fever.		This	evidence-based	algorithm	identifies	appropriate	situations	for	the	use	of	antipyretic	treatments	and	complementary	measures.		This	guideline	does	not	define	what	antipyretic	to	use	or	in	what	amount;	that	was	determined	by	the	established	clinical	guidelines.		 The	second	intervention	is	a	fever	facts	sheet	(see	appendix	B),	which	provides	evidence-based	information	for	the	parent	or	caregiver	on	how	to	appropriately	address	fever	in	their	child.		This	does	not	give	advice	on	which	antipyretic	to	use	or	what	quantity	to	give;	it	only	discusses	how	to	recognize	fever	and	explains	when	it	is	appropriate	to	use	non-pharmacologic	treatments	or	antipyretics.	
Comparison			The	project	compared	the	two	innovations,	and	their	resulting	clinical	protocols,	to	the	current	practice.		Previously,	when	a	pediatric	patient	with	fever	presented	in	the	clinic,	it	was	up	to	the	health	care	team	to	determine	an	individual	treatment	plan.		The	goal	of	this	project	was	to	improve	the	outcomes	by	establishing	a	protocol	for	all	qualifying	patients.		Evaluation	success	was	based	on	the	comparison	trends	after	all	data	had	been	collected.	
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Sample		 There	were	two	target	populations	for	this	project:	(a)	the	parents/caregivers	of	febrile	pediatric	patients,	and	(b)	the	health	care	team	of	UCWM.		The	first	population	for	this	project	was	all	qualifying	pediatric	patients,	and	their	parents/caregivers,	who	presented	at	UCWM	from	July	2017	through	October	2017.		The	second	population	for	this	project	was	the	UCWM	employees	who	interacted	with	the	qualifying	pediatric	population	from	July	2017	through	October	2017.		 The	pediatric	sample	populations	included	two	pre-intervention	sub	sets	as	well	as	one	post-intervention	sub	set.		The	pre-intervention	subsets	included	febrile	pediatric	patients,	aged	six	months	to	six	years,	who	presented	with	uncomplicated	illness	from	July	2015	through	October	2015	and	July	2016	through	October	2016.		The	post-intervention	group	was	the	parents	of	the	febrile	pediatric	patients,	aged	six	months	to	six	years,	who	presented	with	uncomplicated	illness	from	July	2017	through	October	2017.		All	patients	meeting	the	inclusion	criteria,	during	the	stated	months,	were	included	in	the	project.			
Mediating	Factors			The	guideline	and	fever	facts	sheet	were	the	primary	factors	impacting	the	outcomes,	however	there	were	still	some	mediating	factors	present.		The	first	was	making	sure	the	users	understood	the	material,	which	was	addressed	through	education.		The	second	was	creating	buy	in	and	instilling	faith	in	the	users,	which	was	addressed	with	the	engagement	plan.		The	last	mediating	factor,	and	most	difficult	to	address,	was	the	ingrained	views	of	fever	and	treatment	of	fever.		This	
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“fever	phobia”	was	hard	to	overcome	during	one	visit	and	has	to	be	considered	a	dynamic	issue	that	takes	a	much	longer	timeframe	to	properly	address.	
Data	Management	Plan	
	 A	successful	data	management	plan	establishes	credibility	during	the	data	collection	process.		This	is	done	through	having	valid,	reliable,	and	accurate	data	elements	from	a	data	source	with	the	same	qualities.		The	plan	also	assures	that	the	measures	are	appropriate	and	can	be	used	to	evaluate	the	impact	of	the	interventions.	
Data	Sources			
	 The	only	source	of	data	was	the	charts	of	the	qualifying	patients,	which	included	the	initial	visit	as	well	as	any	follow-up	discussions	concerning	fever.		The	data	collected	for	these	sampling	groups	was	based	on:	
• Patient’s	fever:	chief	complaint	vs.	symptom	
• Whether	a	temperature	was	obtained	before	the	visit	
• Whether	the	value	was	correctly	defined	as	a	fever	
• If	an	antipyretic	was	used	
• If	the	patient	was	also	presenting	with	discomfort	
• What	the	temperature	value	was	at	the	time	of	the	visit	
• Which	route	was	used	to	take	the	temperature	
• If	the	clinical	value	was	appropriately	defined	as	a	fever	
• If	the	patient	was	presenting	with	discomfort	
• If	appropriate	action	was	taken	
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• If	the	call	backs	or	follow	up	calls	suggest	a	lack	in	knowledge	or	need	for	education		
• If	the	education	done	was	viewed	as	helpful	to	the	parents/caregivers	Table	2	shows	which	data	elements	correspond	to	each	outcome.		Table	2		
Outcomes	and	their	Corresponding	Data	Elements	(Data	Source	is	Qualifying	Pediatric	
Charts)	
Appropriate	recognition	and	
treatment	of	fever		
Call	backs	and	follow	up	concerning	
fever	Fever	–	reported	as	chief	complaint	or	symptom	 Fever	–	reported	as	chief	complaint	or	symptom	Existence	of	pre-visit	temperature	values	 Existence	of	pre-visit	temperature	values	Clinical	presentation	of	fever	with/without	discomfort	 Was	an	antipyretic	given	before	the	visit	Antipyretic	given	in	clinic	 Was	the	antipyretic	warranted	Was	the	antipyretic	warranted	 Were	there	concerns	discussed	during	the	call	back		Was	an	antipyretic	not	given	when	warranted,	if	yes,	is	there	a	reason	why	 Was	the	fever	facts	sheet	found	to	be	helpful		The	data	elements	applicable	to	both	outcomes	were:	
• Month	
• Year	
• Fever	reported	as	chief	complaint	or	as	a	symptom	
• Existence	of	actual	temperature	values	taken	before	clinic	visit	
• Presentation	of	actual	fever	with	or	without	discomfort	prior	to	visit	
• Antipyretic	administered	prior	to	visit	
AN	ANTIPYRETIC	GUIDELINE	FOR	PEDIATRIC	PATIENTS		
 49 
The	data	elements	applicable	only	to	recognition	and	appropriate	treatment	of	fever	were:	
• Clinical	temperature	value	with	or	without	discomfort	
• Antipyretic	treatment	administered	in	the	clinic	
• Was	the	administration	of	an	antipyretic	warranted	for	this	situation	
• Was	an	antipyretic	warranted	and	not	given	The	data	elements	applicable	only	to	call	backs	and	follow	up	concerning	fever	were:	
• Were	there	concerns	discussed	during	the	call	back		
• Was	the	fever	facts	sheet	found	to	be	helpful		 All	data	elements	were	gathered	from	the	initial	visit	except	for	the	data	elements	applicable	only	to	call	backs	and	follow	up	concerning	fever;	those	were	gathered	from	the	follow-up	discussions.	
Data	Collection	Procedures			The	DNP	student,	to	assure	consistency	in	collection,	was	the	only	individual	collecting	data	from	the	charts.		The	important	data	elements	were	identified,	recorded,	and	then	organized	into	an	excel	spreadsheet.		The	information	gathered	from	the	follow-up	discussions	was	also	used	for	qualitative	data,	to	determine	the	effectiveness	of	the	fever	facts	sheet	and	if	clinical	education	needed	to	be	modified.			There	was	a	month-to-month	collection	of	data,	which	occurred	one	week	after	each	month	ended	(i.e.,	the	first	week	of	the	new	month);	this	accounted	for	time	needed	for	possible	call	backs	from	the	patients’	families	and	follow	up	phone	calls	from	the	DNP	student.		This	collection	procedure	is	a	T-1/T-2	method,	which	
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consists	of	baseline	data	that	has	been	collected	from	qualifying	charts	of	patients	who	were	seen	before	implementation	(T-11	and	T-12).		The	post-intervention	data	was	collected	from	qualifying	charts	(T-2	through	T-5),	on	a	month-to-month	basis.		The	first	collection	was	planned	for	August	7th.		This	first	collection	was	T-2,	with	each	subsequent	collection	time	being	T-3	through	T-5.		The	data	were	then	analyzed	and	trends	among	data	elements	provided	a	picture	of	how	the	innovations	affected	the	outcomes.				The	call	back	and	follow	up	call	discussions	were	the	responsibility	of	the	DNP	student;	there	was	a	follow	up	call	within	48	hours	of	the	initial	visit	to	assess	the	antipyretic	education	done	during	the	visit.		This	consisted	of	three	scripted	questions	that	were	recorded	along	with	their	answers.		The	questions	on	the	fever	call	back	guide	were:	
• Do	you	have	any	concerns	about	your	child’s	fever?	
• What	has	the	temperature	been,	has	your	child	shown	signs	of	discomfort,	and	have	you	been	doing	anything	to	treat	it?	
• What	is	your	opinion	about	the	fever	facts	sheet	and	education	provided	in	the	clinic?		 The	data	were	stored	in	an	unmarked	file	on	the	DNP	student’s	laptop,	which	has	password	protection	that	only	allows	him	access.		The	monthly	data	collection	did	not	record	names	or	other	patient	identifiers,	so	the	anonymity	of	the	patient	and	parents/caregiver	has	been	assured.		The	individual	data	elements	were	integrated	into	monthly	categories,	which	removed	the	individual	component	altogether.		There	was	an	identifier	key	on	a	separate	spreadsheet	to	allow	for	
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review	of	an	individual	chart	if	needed.		This	has	not	been	stored	with	any	of	the	data	elements.			
Data	Analysis	Plan			
	 Data	that	were	analyzed	are	a	mix	of	qualitative	and	quantitative	descriptive	results.		The	primary	outcomes	are	the	percentage	of	times	fever	is	correctly	recognized	and	treated	in	the	clinic,	as	well	as	how	many	parents	continued	to	have	questions	about	fever	after	the	education	done	in	the	clinic.	There	was	one	qualitative	element	concerning	the	call	backs	from	parents	or	caregivers	and	the	follow	up	calls	from	the	DNP	student.		The	focus	was	on	the	identification	of	gaps	in	knowledge,	why	the	gaps	are	there,	and	how	the	gaps	can	be	closed.		The	results	were	reported	based	on	trends	in	descriptive	data	and	content	of	the	follow	up	dialogue	concerning	the	fever	education.		
	
Data	Presentation	Plan			Stakeholders	were	presented	with	the	descriptive	data	analysis	at	the	end	of	the	implementation	process.		There	were	monthly	updates	on	the	qualitative	data	with	the	intent	of	evaluating	clinical	education.		Interpretation	and	possible	adjustment	to	the	education	plan	was	the	responsibility	of	all	health	care	team	stakeholders.		Once	data	had	been	completely	analyzed,	there	were	informal	meetings	with	the	health	care	team	to	discuss	the	results,	possible	adjustments,	and	plan	for	sustainability.	
Resources		 The	DNP	project	did	require	resources	for	every	phase	in	order	to	be	completed.		There	were	four	categories	of	resources:	financial,	human,	time,	and	
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physical.		These	resources	needed	to	meet	the	minimum	requirements	in	order	for	the	project	to	be	successful.		An	evaluation	of	the	resources	available	as	well	as	what	was	needed	was	done	before	implementation	began.	
Financial			The	monetary	requirements	for	this	project	were	low.		The	only	financial	costs	during	the	implementation	phase	came	from	the	printing	of	the	antipyretic	guideline	and	fever	facts	sheets.		The	outcome	evaluation	phase	did	not	require	any	financial	resources.		In	total,	the	only	financial	burden	was	the	cost	of	professional	printing	of	the	fever	facts	sheets,	which	was	a	minimal	expense	covered	by	the	DNP	student.	
Human			Human	resources	met	the	requirements	of	the	DNP	project.		The	DNP	student	has	completed	the	first	three	phases	of	the	project	with	help	from	the	opinion	leader	and	change	champion.		This	interaction	consisted	of	consultation,	review	of	plans	and	guidance.		The	implementation	phase	had	the	largest	requirement	of	human	resources,	using	all	the	health	care	team	stakeholders	to	successfully	carryout	adoption	and	integration.		The	final	phase,	the	outcome	evaluation	phase,	fell	on	the	shoulders	of	the	DNP	student,	who	was	helped	by	all	members	of	the	health	care	team	stakeholders,	in	the	form	of	feedback,	interpretation,	and	decisions	to	continue	or	sustain	the	project	when	it	was	found	to	be	beneficial.		Human	resources	were	a	substantial	need	for	the	success	of	the	project.		The	health	care	team	was	able	to	meet	the	resource	needs	to	successfully	complete	the	project.	
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Time			Time	was	not	an	issue	for	any	of	the	stages	of	the	DNP	project.		There	was	four	months	for	implementation	and	data	gathering,	which	allowed	for	three	months	for	data	analysis	and	completion	of	the	final	outcome	evaluation	stage.		The	final	stages	required	a	significant	amount	of	time	to	analyze	the	data,	review	with	the	stakeholders,	and	make	decisions	on	sustainability.		The	expected	timeline	of	events	for	program	completion	is	depicted	in	Appendix	C	and	has	been	successfully	followed	throughout	the	project.	
Physical		The	physical	resources	needed	for	completion	were	minimal;	an	on	site	office,	use	of	the	charts	and	filing	cabinets,	and	computer	space	was	sufficient	for	completion.		The	nurses’	office	was	available	for	use	as	needed	and	the	DNP	student’s	computer	had	enough	space	for	data	collection,	storage,	and	analysis.		Past	medical	records	were	available	as	needed.		The	space	provided	met	the	resource	needs	of	the	project.		 This	DNP	project	was	an	integration	of	two	innovations	into	the	daily	pediatric	fever	protocol.		These	innovations	are	guidelines	for	behavior	and	information,	which	demanded	minimal	requirements	of	all	four	resource	categories.		During	the	project,	the	implementation	phase	was	the	biggest	burden	on	resources;	however,	it	did	not	require	more	than	could	be	provided.		There	was	a	sufficient	amount	of	resources	in	order	to	complete	the	DNP	project.	
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Plan	for	Sustainment	of	Practice	Change	
	 There	are	two	practice	changes/innovations	that	were	introduced.		These	are	an	antipyretic	guideline	and	a	fever	facts	sheet.			
Antipyretic	Guideline		 The	antipyretic	guideline	was	focused	on	establishing	a	protocol	for	pediatric	fever	in	the	clinic;	once	implemented	this	should	be	self-sustaining.		New	employees	will	be	taught	the	guideline	when	hired,	assuring	sustainment	as	the	workforce	changes.		Continued	use	of	this	successful	protocol	will	allow	the	doctor	and	PAs	to	focus	their	time	on	the	underlying	issues,	while	the	nurses	can	appropriately	address	fever	independently.	
Fever	Facts	Sheet		 The	fever	facts	sheet	is	a	tool	focused	on	assuring	evidence-based	education	is	being	taught	to	the	patients’	parents	and	caregivers.		Assuring	its	presentation	in	the	pediatric	exam	room	will	provide	a	physical	sustainment	of	this	material.		As	long	as	it	is	available	to	the	target	population,	it	will	continue	to	provide	information.		The	use	of	this	innovation	will	also	rely	on	the	members	of	the	health	care	team	to	continue	to	refer	to	it.		Once	proven	to	be	effective,	the	facts	sheet	will	be	sustained	through	its	ability	to	decrease	discussion	time	and	improve	the	education	process.		Discussion	of	these	topics	will	need	to	take	place	in	order	to	sustain	adoption.		This	will	be	completely	reliant	on	the	stakeholders	of	the	health	care	team.	
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Role	of	Stakeholders			
	 The	health	care	team	stakeholders	must	be	involved	in	the	sustainment	of	both	practice	changes.		If	they	do	not	choose	to	use	the	antipyretic	guideline	or	the	fever	facts	sheet,	neither	innovation	will	exist.		The	medical	director,	as	well	as	the	PA	must	take	an	active	role	with	the	use	and	promotion	of	these	innovations	to	assure	sustainability.		Promotion	will	be	to	their	advantage	because	the	practice	changes	will	free	up	their	time.		The	nurses	will	be	the	main	advocates	for	the	use	of	the	fever	facts	sheet,	since	they	provide	a	large	amount	of	the	education.		The	handout	will	increase	the	ease	of	education,	which	should	give	the	nurses	motivation	to	continuing	using	it.	
	
Human	Subjects	Considerations	
Justification	to	Exclude	IRB	Process			
	 The	Institutional	Review	Board	(IRB)	process	was	not	required	for	this	project	because	no	research	was	conducted.		This	project	was	an	application	of	an	evidence-based	guideline	and	fever	facts	sheet	in	an	urgent	care	environment.		No	untested	treatments	were	used	and	there	were	no	plans	for	randomization	of	subjects	into	different	treatment	arms.		The	project	consisted	of	the	implementation	of	evidence-based	practices	that	were	applied	to	all	eligible	patients.		None	of	the	data	were	linked	to	patient	identifiers.	
Ethical	Considerations		 There	are	four	ethical	tenets	that	need	to	be	discussed:	autonomy,	nonmaleficence,	beneficence,	and	justice	(Polit	&	Beck,	2004).		This	project	allowed	for	autonomy,	or	self-directing	freedom	(Merriam-Webster,	2017),	by	implementing	
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a	guideline	for	use.		This	guideline	is	evidence-based	and	provides	the	health	care	team	and	parents/caregivers	appropriate	information	and	material	to	make	decisions	about	patient	care.		The	decisions	made	were	ultimately	up	to	these	parties,	after	the	information	had	been	presented	to	them	or	the	guideline	had	been	followed.		The	guideline	and	fever	facts	sheet	allowed	for	self-determination,	preserving	autonomy	during	the	process.		 Nonmaleficence,	to	do	no	harm	(Farlex	Partner	Medical	Dictionary,	2012),	was	preserved	during	this	project	by	using	evidence-based	material.		The	project	goals	focused	on	assuring	appropriate	care	in	the	clinical	setting	as	well	as	at	home.		This	minimized	the	chance	that	harm	accidentally	occurred	by	establishing	a	protocol	and	properly	educating	parents	and	caregivers.		 Pediatric	patients	are	brought	to	an	urgent	care	for	the	sake	of	beneficence,	the	principle	of	doing	good	(Farlex	Partner	Medical	Dictionary,	2012);	the	goal	is	to	provide	appropriate	care	where	the	patients	and	parents	benefit.		By	establishing	an	evidence-based	protocol	to	manage	the	febrile	pediatric	population,	the	project	increased	the	likelihood	that	the	clinical	visit	was	beneficial	to	the	patients	and	their	parents.		The	results	minimized	risk	while	maximizing	benefit.		 Justice,	or	fair	and	equal	treatment	for	all	(Mosby's	Medical	Dictionary,	2009),	was	another	goal	of	the	project.		The	focus	of	this	project	was	to	assure	consistency	and	a	standard	of	care	when	treating	a	child	with	fever.		Justice	was	inherent	in	the	outcomes,	with	underlying	goals	of	all-inclusivity	and	consistency	in	treatment	and	educational	protocols.		One	of	the	foci	of	this	project	was	to	assure	justice	when	treating	the	febrile	pediatric	patient.		
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	 This	project	was	an	integration	of	evidence-based	guidelines	and	education	into	an	urgent	care	setting	with	the	focus	on	improving	care.		Research	was	not	conducted	during	this	project;	rather	the	focus	was	to	evaluate	an	improvement	in	the	standards	of	care.		Ethical	considerations	have	been	acknowledged	and	were	maintained	throughout	the	duration	of	the	project.	
Limitations		 There	were	limitations	that	must	be	addressed	in	this	project.		With	a	non-research	project,	variables	cannot	all	be	controlled,	which	allows	for	variations	in	risk	and	findings.		The	number	of	patients,	seasonal	characteristics,	and	length	of	time	are	all	limited	by	the	parameters	of	this	project.		These	factors	may	result	in	skewed	data	or	minimize	the	potential	for	sustainability.		And	finally,	the	data	being	used	came	from	paper	charts,	which	allows	for	individual	interpretation	of	a	situation,	which	may	also	result	in	variability	and	limit	validity.	
Summary		 The	purpose	of	this	DNP	project	was	to	implement	a	pediatric	antipyretic	guideline	and	fever	facts	sheet,	in	an	urgent	care	setting,	to	maximize	the	goals	of	recognition	and	appropriate	treatment	of	fever,	as	well	as	increase	parental	and	caregiver	fever	guideline	compliance.	This	chapter	is	guided	by	step	four	of	the	ACE	Star	Model	of	Knowledge	Transformation,	focusing	on	the	integration	of	the	innovations	into	clinical	practice.		Chapter	three	discusses	what	the	implementation,	evaluation,	and	dissemination	plans	of	the	project	were	and	evaluates	the	resources,	human	subjects	considerations,	and	limitations	inherent	to	the	project.		
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Chapter	4:	Results		 This	chapter	discusses	the	results	of	the	implementation	plan	and	the	data	that	were	gathered	before,	during,	and	after.		Descriptions	of	the	sample,	trends	in	the	outcome	and	process	variables,	as	well	as	expected	versus	actual	outcomes	will	be	discussed.		The	chapter	ends	with	the	facilitators	and	barriers	that	were	noted	during	the	implementation	phase	of	the	project.	
Objectives		 There	were	two	objectives	for	this	DNP	project.		One	was	a	95%	recognition	and	appropriate	treatment	of	fever	in	clinic	by	the	UCWM	health	care	team,	and	the	second	was	a	95%	recognition	and	appropriate	treatment	of	fever,	post-visit,	by	the	parents/caregivers	of	the	pediatric	patients.	
Description	of	Sample		 There	were	a	total	number	of	239	patients	who	were	seen	and	met	eligibility	criteria	for	the	months	of	July	through	October	during	the	years	2015	through	2017.		The	breakdown	by	year	for	patients	seen	who	met	the	eligibility	criteria	was	85	qualifying	pediatric	patients	in	2015,	85	qualifying	pediatric	patients	in	2016,	and	69	qualifying	pediatric	patients	in	2017.		The	most	common	diagnoses	noted	for	these	patients	were:	acute	otitis	media	in	154	patients	(66%);	acute	pharyngitis	in	49	patients	(20%);	acute	sinusitis	in	22	patients	(9%);	and	14	patients	(6%)	with	other	diagnoses	(refer	to	figure	5).						
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Figure	5.	Underlying	Diagnoses	for	the	Qualifying	Pediatric	Patients	
	Of	the	total	number	of	patients,	228	(95%)	were	visitors	to	the	island	while	11	(5%)	resided	in	Hawaii.		The	majority	of	patients	(n=196,	82%)	were	residents	of	the	U.S.	while	the	remainder	(n=43,	18%)	were	international	patients	(refer	to	figure	6).		The	majority	of	international	patients	reported	that	they	were	Canadian	(n=26,	61%),	followed	by	those	identifying	as	Australian	(n=6,	14%)	or	German	(n=4,	9%);	the	remainder	(n=7,	16%)	were	from	other	countries	(refer	to	figure	7).	
Figure	6.	United	States	vs.	International	Patient	Population	Breakdown	
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Figure	7.	International	Patient	Population	Breakdown	
	
Trend	Analysis	for	Process	&	Outcome	Variables	
Clinical	Trends:	Pre-Implementation	Pre-implementation	data	collected	in	2015	found	that	80	of	85	pediatric	patients	(94%)	were	appropriately	treated	for	fever,	while	in	2016,	79	of	85	pediatric	patients	(93%)	were	appropriately	treated	for	fever	(refer	to	figure	8).		The	rates	for	appropriate	treatment	of	pediatric	patients	per	month	were	as	follows:	21	of	23	pediatric	patients	(91%)	in	July;	21	of	22	pediatric	patients	(95%)	in	August;	21	of	21	pediatric	patients	in	September;	and	17	of	19	pediatric	patients	(89%)	in	October.		For	2016,	appropriate	monthly	antipyretic	treatment	occurred	in	20	of	22	patients	(91%)	in	July,	20	of	22	patients	(91%)	in	August,	19	of	20	patients	(95%)	in	September,	and	20	of	21	patients	(95%)	in	October	(refer	to	figure	9).					
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Figure	8.	Appropriate	Antipyretic	Administration	Rates	Given	at	the	UCWM,	Four-Month	Totals	for	2015	and	2016	
	
Figure	9.	Appropriate	Antipyretic	Administration	Rates	Given	at	the	UCWM	–Monthly	Totals	for	2015	and	2016	
	Of	the	five	inappropriately	treated	patients	in	2015,	three	were	not	given	an	antipyretic	when	it	was	warranted	and	two	were	given	an	antipyretic	when	it	was	
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not	warranted.		Of	the	six	inappropriately	treated	patients	in	2016,	four	were	not	given	an	antipyretic	when	it	was	warranted	and	two	were	given	an	antipyretic	when	it	was	not	warranted.	
Parent/Caregiver	Trends	Pre-implementation	data	collected	found	that	in	2015,	parents	and	caregivers	appropriately	gave	antipyretics	before	their	urgent	care	visit	54	of	85	times	(64%),	and	53	of	85	times	(62%)	in	2016.		After	urgent	care	visits	in	2015,	eight	of	14	pediatric	patients	(57%)	received	appropriate	antipyretic	treatment,	while	in	2016,	24	of	38	qualifying	pediatric	patients	(63%)	received	appropriate	antipyretic	treatments	(refer	to	figure	10).		There	was	no	protocol	that	was	used	regarding	telephone	calls	(i.e.,	“call	backs”)	to	parents/caregivers	after	an	urgent	care	visit	at	the	UCWM	before	2017;	therefore,	the	data	collected	about	this	were	low.			 										
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Figure	10.	Appropriate	Parent/Caregiver	Antipyretic	Administration	Rates	Pre-Visit	and	Post-Visit	for	2015	and	2016	
	The	inappropriate	parent/caregiver	administration	of	antipyretics	was	consistently	due	to	administering	doses	when	not	warranted.		In	2015,	24	of	31	patients	(77%)	before	the	urgent	care	visit	and	5	of	6	(83%)	patients	after	the	urgent	care	visit	were	given	doses	when	it	was	unnecessary.		The	remaining	patients,	seven	patients	(23%)	before	their	urgent	care	visit	and	one	patient	(17%)	afterwards	should	have	received	doses	when	they	had	not.		This	is	also	consistent	for	2016,	with	27	of	32	patients	(84%)	before	their	urgent	care	visit	and	12	of	14	patients	(86%)	after	their	urgent	care	visit	were	given	unnecessary	doses,	while	five	patients	(16%)	before	the	urgent	care	visit	and	two	patients	after	(14%)	missed	doses	they	should	have	received.				 There	was	a	difference	noted	in	pre-visit	antipyretic	administration	patterns	depending	on	the	nationality	of	the	patients	and	their	parents/caregivers.		The	
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families	from	the	U.S.	were	found	to	properly	administer	antipyretics	less	often	with	121	out	of	196	American	patients	(62%)	noted	to	have	administered	antipyretics	appropriately,	compared	to	38	out	of	43	international	patients	(88%).		The	Canadian	families	appropriately	administered	antipyretics	22	out	of	26	times	(85%),	the	Australian	families	5	out	of	6	times	(83%),	the	German	families	4	out	of	4	times	(100%),	and	all	other	international	families	7	out	of	7	times	(100%).		It	was	also	found	that,	in	the	majority	of	instances,	American	families	erred	by	giving	an	antipyretic	when	it	was	not	needed	(61	out	of	75	occurrences	[81%]),	compared	to	having	missed	an	antipyretic	when	it	was	indicated	(14	out	of	75	times	[19%]).		Canadian	families	were	evenly	split	with	50%	noted	to	have	missed	an	opportunity	to	give	an	antipyretic	and	50%	giving	an	antipyretic	when	it	was	not	needed.		There	was	one	Australian	family	out	of	four	(25%)	that	did	not	administer	an	antipyretic	when	it	was	deemed	appropriate.	
Project	Outcomes	Post	Implementation	
Expected	versus	Actual	Project	Outcomes	
UCWM	health	care	team	success.	All	69	eligible	qualifiers	in	2017	were	included	in	the	project	with	all	69	(100%)	appropriately	treated.	For	2017,	this	exceeded	the	95%	goal	for	each	month	and	as	a	total	across	all	months	(refer	to	figures	11	and	12).						
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Figure	11.	Appropriate	Antipyretic	Administration	Rates	Given	at	the	UCWM	–	Monthly	Totals	for	2015,	2016,	and	2017	
	
Figure	12.	Appropriate	Antipyretic	Administration	Rates	Given	at	the	UCWM	–	Pre-visit	and	Post-visit	Four-Month	totals	for	2015,	2016,	and	2017	
	
Parent/caregiver	success.	In	2017,	there	were	65	out	of	69	eligible	parents/caregivers	who	were	contacted	by	telephone	after	their	children’s	urgent	care	visits,	with	63	of	65	(97%)	parents/caregivers	appropriately	treating	fever	
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only	in	the	presence	of	discomfort.		The	2017	post-intervention	four-month	total	for	the	number	of	parents/caregivers	who	used	antipyretic	treatment	appropriately	met	the	project’s	goal	of	95%	(refer	to	figure	13).		However,	monthly	rates	of	parent/caregiver	appropriate	use	of	antipyretic	treatment	did	not	consistently	meet	the	95%	goal.		Specifically,	the	months	of	July	and	August	did	not	reach	the	95%	goal,	although	both	had	a	rate	of	94%.		In	July,	16	of	17	parents/caregivers	(94%)	appropriately	treated	while	in	August	15	of	16	parents/caregivers	(94%)	appropriately	treated.		There	was	a	total	of	two	parental/caregiver	antipyretic	administration	errors,	both	due	to	their	giving	a	dose	when	it	was	not	appropriate.		Both	September	(15	of	15)	and	October	(17	of	17)	were	noted	to	have	100%	of	parents/caregivers	having	used	antipyretics	appropriately	(refer	to	figure	14).		
Figure	13.	Appropriate	Parent/Caregiver	Antipyretic	Administration	Rates	Pre-visit	and	Post-visit	Four-Month	totals	for	2015,	2016,	and	2017	
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In	2017,	all	four	months	saw	a	post-urgent	care	visit	improvement	of	antipyretic	administration	when	compared	to	the	pre-urgent	care	visit	antipyretic	administration	(refer	to	figure	14).		July	recorded	16	of	19	patients	(84%),	August	recorded	9	of	18	patients	(50%),	September	recorded	11	of	15	patients	(73%),	and	October	recorded	16	of	19	patients	(84%)	receiving	appropriate	antipyretic	treatment.		The	improper	dosing	was	more	often	due	to	inappropriate	administration	of	the	antipyretic	(12	of	the	17	occurrences	[71%])	instead	of	missed	appropriate	doses	(5	of	the	17	occurrences	[29%]).		
Figure	14.	Parent/Caregiver	Pre-Visit	vs.	Post-Visit	Appropriate	Antipyretic	Administration	Rates	-	Monthly	Totals	for	2017	
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fever	facts	sheet,	previous	knowledge	of	the	health	care	team	and	parents/caregivers	about	the	treatment	of	fever,	and	the	DNP	student	assuming	the	lead	RN	position	at	the	UCWM.		During	implementation	of	the	project,	the	parents/caregivers	and	health	care	team	all	shared	the	common	desire	to	help	the	pediatric	patients.		This	helped	provide	a	common	ground	and	increased	receptivity	to	the	project’s	goals.		The	simplicity	of	the	antipyretic	guideline	and	fever	facts	sheet	made	for	a	smooth	transition,	facilitating	implementation	into	the	urgent	care	and	home	environments.		All	parties	involved	noted	the	ease	of	use	of	these	items.		For	the	most	part,	the	knowledge	previously	learned	by	the	health	care	team	and	the	parents/caregivers	was	aligned	with	the	material	being	presented.		All	health	care	team	members	had	previous	knowledge	of	this	information,	and	the	majority	of	the	parents/caregivers	had	heard	of	at	least	a	portion	of	the	material.		This	previous	knowledge	and	understanding	made	the	implementation	of	the	project	easier	and	typically	made	discussions	with	the	parents/caregivers	more	productive.		The	DNP	student	holds	the	lead	RN	position	at	the	urgent	care	and	has	been	working	there	for	over	three	years.		This	resulted	in	better	buy-in	of	the	staff,	use	of	pre-existing	relationships	and	lines	of	communication,	and	increased	face	time	at	the	urgent	care	site	during	all	phases	of	the	project.	
Barriers	Traditional	beliefs,	previous	workplace	policy,	and	turnover	in	the	clinic	were	barriers	to	the	project’s	implementation.		A	small	population	of	the	parents/caregivers	held	beliefs	that	all	fever	needed	to	be	treated	no	matter	what.		This	created	a	barrier	to	learning	and	mistrust	about	the	content	regarding	fever	
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treatment	being	implemented	for	the	project.		One	of	the	providers	had	come	from	another	facility	where	they	were	more	aggressive	with	their	antipyretic	administration.		This	created	an	initial	barrier,	however,	it	was	resolved.		The	last	barrier	was	the	turnover	rate	of	the	health	care	team,	including	nurses	and	physician	assistants,	during	the	implementation	process.		This	resulted	in	an	increased	need	for	teaching	new	staff	about	the	project	and	a	delay	in	maintaining	continuity	for	the	health	care	team’s	activities.		
Summary		 The	project	implementation	was	successfully	completed	with	almost	all	of	the	expected	outcomes	and	objectives	met.		After	the	project	implementation	in	2017,	the	health	care	team	members	successfully	surpassed	the	95%	recognition	and	appropriate	treatment	of	fever	goal	at	the	UCWM	during	all	four	months	of	implementation.		The	parents/caregivers	of	the	pediatric	patients	did	not	meet	the	desired	95%	goal	for	recognition	and	appropriate	treatment	of	fever	during	the	first	two	months.		However,	this	goal	was	met	during	the	last	two	months	of	the	project	and	for	the	combined	overall	four-month	total.	
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Chapter	5:	Discussion		 This	chapter	discusses	the	findings	presented	in	Chapter	4	and	their	implications.	It	provides	an	interpretation	of	the	results,	connects	the	DNP	project	to	the	American	Association	of	Colleges	of	Nursing	(AACN)	Doctoral	Essentials,	and	describes	plans	for	dissemination	of	the	project’s	findings.	
Interpretation	of	Findings	
Clinical	Findings	
	 The	UCWM	health	care	team	was	100%	successful	in	reaching	the	post-intervention	monthly	and	four-month	goals	of	95%	recognition	and	appropriate	treatment	of	fever	(refer	to	figures	11	and	12).		These	results	suggest	(a)	the	health	care	team	is	willing	to	incorporate	new	guidelines	into	practice,	(b)	the	antipyretic	guideline	is	applicable	to	the	clinical	environment,	and	(c)	an	antipyretic	guideline	can	help	to	eliminate	inappropriate	antipyretic	administration.		For	this	goal	to	be	met,	the	health	care	team	had	to	assimilate	the	new	antipyretic	guideline	into	their	practice,	and	the	guideline	had	to	be	user	friendly.		The	perfect	success	rate	suggests	the	health	care	team	members	correctly	utilized	the	antipyretic	guideline	that	was	developed	and	implemented.				 The	improvement	of	appropriate	antipyretic	administration	from	pre-implementation	to	post-implementation	suggests	that	the	antipyretic	guideline	is	a	useful	tool	when	trying	to	eliminate	inappropriate	antipyretic	administration.		In	2015	and	2016	the	clinic	had	a	94%	and	93%	appropriate	antipyretic	administration	success	rate,	respectively	(refer	to	figure	18).		After	implementation	
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the	success	rate	increased	to	100%,	suggesting	that	the	use	of	the	algorithm	can	reduce	the	number	of	inappropriate	administration	occurrences	(refer	to	figure	12).	Another	finding	suggests	the	UCWM	education	for	antipyretic	use	has	positively	affected	the	outcomes	for	the	team’s	patients.		In	2015	and	2016,	before	implementation,	there	was	no	improvement	in	post-visit	parent/caregiver	appropriate	antipyretic	administration	rates	when	compared	to	pre-visit	rates.		In	2015	appropriate	antipyretic	administration	went	down	after	the	urgent	care	visit,	from	64%	to	57%;	while	in	2016	there	was	a	minimal	increase	from	62%	to	63%	(refer	to	figure	10).		After	implementation	of	the	fever	facts	sheet	by	the	health	care	team	in	2017,	there	was	a	significant	increase	in	appropriate	parent/caregiver	antipyretic	administration;	before	the	urgent	care	visit	there	was	75%	appropriate	antipyretic	administration	by	parents/caregivers,	afterwards	this	increased	to	97%	appropriate	administration	(refer	to	figure	13).		The	parents/caregivers	reported	that	the	fever	facts	sheet	was	informative	and	helpful	in	guiding	their	treatment	choices,	which	is	reflected	in	the	improvement	of	their	appropriate	antipyretic	use	in	their	children.	
Parent/Caregiver	Findings		 The	failure	to	reach	the	95%	success	rate	for	parent/caregiver	appropriate	antipyretic	administration	during	the	months	of	July	and	August	2017	may	be	due	to	lack	of	a	large	enough	sample	size,	parent/caregiver	non-compliance,	or	continued	misunderstanding	about	fever	treatment,	and/or	heath	care	team	member	inexperience	with	the	fever	facts	sheet.		All	these	issues	need	to	be	considered	in	future	application	of	this	process.		It	is	reassuring	that	in	the	last	two	months	of	
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implementation	(September	and	October	2017),	the	rates	of	parent/caregiver	appropriate	antipyretic	administration	reached	the	objective	goal	(a	minimum	of	95%	of	parents/caregivers).	The	findings	suggest	important	clinical	aspects	including:	(a)	Most	parents	are	willing	to	adapt	to	updated	guidelines	concerning	their	children;	(b)	The	fever	facts	sheet	is	a	successful	teaching	tool;	and	(c)	parents’/caregivers’	knowledge	of	appropriate	antipyretic	use	can	be	improved	with	simple	educational	interventions	such	as	the	one	being	used	for	this	project.		There	is	still	room	for	improvement	based	on	the	findings	of	the	project.		As	discussed	in	the	previous	chapter,	during	2015	and	2016	(prior	to	the	implementation	of	the	project),	the	parents/caregivers	of	the	pediatric	patients	demonstrated	poor	antipyretic	administration	decisions	that	did	not	improve	after	the	urgent	care	visits.		Before	the	urgent	care	visit	for	evaluation	of	children’s	fevers,	parent/caregiver	appropriate	antipyretic	administration	rates	for	2015	and	2016	were	64%	and	62%,	and	after	the	urgent	care	visit	they	were	57%	and	63%	respectively.		This	suggests	that	just	over	half	of	the	parents/caregivers	were	administering	antipyretic	treatment	appropriately,	according	to	the	American	Academy	of	Pediatrics’	(Sullivan	&	Farrar,	2011),	six	out	of	every	ten	times.		The	urgent	care	visits	these	pediatric	patients	had	were	not	helping	to	improve	changes	in	parent/caregiver	behaviors	about	the	treatment	of	fever	for	their	children.		In	2017	the	parent/caregiver	pre-visit	appropriate	administration	rates	were	at	75%	and	they	increased	to	95%	post-visit.		The	2017	increase	in	appropriate	treatments	from	the	pre-visit	rates	to	the	post-visit	rates	
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suggests	the	parents	are	receptive	to	the	teaching	they	received,	and	that	the	fever	facts	sheet	is	a	successful	teaching	tool.				 The	pre-visit	appropriate	antipyretic	administration	rates	indicate	that	parent/caregiver	knowledge	about	appropriate	antipyretic	administration	improved	in	2017	(75%)	when	compared	to	rates	noted	in	2015	(64%)	and	2016	(62%).		However,	the	75%	rate	still	has	room	for	improvement.		Parents	and	caregivers	should	always	be	giving	antipyretics	in	accordance	to	the	American	Academy	of	Pediatrics’	guidelines	(Sullivan	&	Farrar,	2011);	hopefully	these	rates	will	continue	to	improve.				 The	findings	provide	some	evidence	that	there	is	a	cultural	effect	on	appropriate	administration	rates.		American	parents	and	caregivers	followed	appropriate	administration	guidelines	62%	of	the	time,	which	is	low	when	compared	to	the	Canadian	(85%),	Australian	(83%),	German	(100%)	parents/caregivers,	and	those	from	other	countries	(100%).		American	parents	are	far	more	likely	to	administer	a	dose	of	an	antipyretic	when	it	is	not	needed,	whereas	international	parents	err	on	the	side	of	withholding	an	antipyretic	when	it	is	deemed	to	be	necessary.		Looking	at	the	incorrect	treatments,	American	parents	gave	an	inappropriate	dose	81%	of	the	time,	while	they	inappropriately	held	a	dose	19%	of	the	time.		The	international	parents	incorrect	treatments	were	divided	more	evenly;	60%	were	due	to	holding	an	antipyretic	while	40%	were	due	to	giving	a	dose	when	it	was	not	warranted.		These	findings	suggest	American	parents	and	caregivers	may	be	quicker	to	administer	an	antipyretic	medication	than	their	international	counterparts.	
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Implications/Recommendations		 The	findings	of	the	project	suggest	the	antipyretic	guideline	algorithm	and	fever	facts	sheet	should	continue	to	be	used	in	the	urgent	care	setting.		The	antipyretic	algorithm	should	continue	to	be	posted	in	the	laboratory,	next	to	the	pediatric	antipyretic	medications,	to	be	reviewed	before	antipyretics	are	administered.		The	fever	facts	sheet	should	continue	to	be	posted	in	the	pediatric	exam	room	and	reviewed	when	appropriate.		Both	tools	should	be	discussed	with	new	health	care	team	hires	prior	to	beginning	work.		Follow-up	calls	to	parents/caregivers	of	the	pediatric	patients	should	continue	to	be	made	within	24	to	48	hours	of	any	urgent	care	visit	to	review	appropriate	use	of	antipyretic	medications.	
DNP	Project	Process	and	Relationship	to	Doctoral	Essentials		 As	the	DNP	student	developed	the	practice	change	project,	activities	were	completed	that	reflected	the	application	of	knowledge	and	use	of	skills	that	helped	achieve	the	implementation	and	evaluation	of	the	project.		Table	3	depicts	specific	activities	that	were	completed	per	each	Doctoral	Essential.								
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Table	3	
DNP	Project	Correlation	to	the	American	Association	of	Colleges	of	Nursing	Essentials	
Essential	 DNP	Student	Activity	
I:	Scientific	Underpinnings	for	
Practice	
Literature	review	and	the	use	of	the	American	Pediatric	Guidelines	and	Italian	Pediatric	Society	Guidelines	
II:	Organizational	&	Systems	
Leadership	for	QI	&	Economics	
Lead	role	in	the	development	and	implementation	of	the	DNP	project	
III:	Evidence-Based	
Practice/Translation	Science	
Synthesis	of	the	research	and	development	of	the	antipyretic	guideline	and	fever	facts	sheet	
IV:	Information	Systems/Technology	 The	use	of	patient	records	and	computer	programs	to	develop,	collect,	and	analyze	the	data	
V:	Health	Care	Policy	&	Ethics	 Establishment	of	a	clinical	protocol	for	pediatric	fever	
VI:	Inter-professional	Collaboration	 Collaboration	with	the	health	care	team	members	–	doctor,	physician	assistants,	and	nurses	
VII:	Prevention	and	Population	
Health	
Education	and	collaboration	with	the	parents/caregivers	of	the	pediatric	patients	to	decrease	unnecessary	antipyretic	use	
VIII:	Advanced	Nursing	Practice	&	
Education		
The	implementation	of	an	antipyretic	guideline	and	fever	facts	sheet	to	update	antipyretic	use,	in	accordance	to	the	latest	guidelines,	in	the	clinical	and	home	settings	
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Plans	for	Dissemination	
	 The	results	of	this	DNP	project	were	discussed	with	the	health	care	team	at	the	UCMW	and	included	the	recommendation	to	continue	the	use	of	the	antipyretic	guideline	and	fever	facts	sheet.		The	project	was	discussed	at	the	final	defense	presentation	that	was	open	to	the	public	and	held	on	March	1,	2018.		A	manuscript	is	being	considered	that	will	describe	the	process	and	outcomes	of	this	project	so	other	health	care	facilities	can	consider	this	approach	to	achieving	a	goal	of	appropriate	antipyretic	administration	by	health	care	providers	and	parents/caregivers	of	children.	
Summary		 This	project	was	successful	in	achieving	the	health	care	team	stated	objective,	and	partially	successful	in	meeting	the	parent/caregiver	focused	objective.		Both	tools	developed	during	the	project,	the	antipyretic	guideline	and	the	fever	facts	sheet,	have	been	shown	to	be	effective	in	establishing	a	successful	UCWM	clinical	protocol	and	increasing	appropriate	guideline-based	antipyretic	treatments	for	pediatric	patients	by	their	parents	or	caregivers.				 The	DNP	project	addressed	all	eight	of	the	AACN	Doctoral	Essentials	that	guide	advanced	nursing	practice.		A	plan	was	been	developed	for	dissemination	of	the	project’s	findings,	especially	focusing	on	the	UCWM	staff	as	well	as	the	public	during	the	DNP	student’s	final	defense	presentation	in	early	March	2018.		The	goal	to	improve	clinical	practice,	consistency	of	care,	and	parent/caregiver	knowledge	about	appropriate	fever	treatment	has	been	successful,	even	though	all	objectives	were	not	met.	
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Appendix	A	
Pediatric	Antipyretic	Guideline	
	
	
Antipyretic*Guideline*Algorithm**For*a*pediatric*patient*aged*6*months*to*6*years*old*Non8emergent*presentation*without*complicated*illness**(This*algorithm*is*a*suggested,*but*not*exhaustive,*approach*to*management)** Temperature*Rectal**≥100.4*°F*or*38*°C*Tympanic*≥100.4*°F*or*38*°C*Axilla*≥99*°F*or*37.3*°C*Oral*≥99.5*°F*or*37.5*°C**Recommended* Monitor*Encourage*fluids*and*encourage*rest123**Presenting*with*discomfort?*
Yes* No*
No*
Yes*
Administer*antipyretic*medication123**Encourage*fluids,*rest,*light*clothing,*indirect*air*circulation,*and*decreasing*ambient*air*temperature*Educate*parents/caregivers*that*the*goal*is*to*alleviate*discomfort.123*
Discomfort*decreased*after*three*hours?* Yes*
No*
Consider*switching*to*the*alternative*antipyretic*medication3**Encourage*fluids,*rest,*light*clothing,*indirect*air*circulation,*and*decreasing*ambient*air*temperature.*Educate*parents/caregivers*that*the*goal*is*to*alleviate*discomfort.123*
Discomfort*decreased*after*three*hours?* Yes*No*
Continue*non8pharmacologic*therapies,*focus*attention*on*finding*the*source*of*infection.**If*no*source*can*be*identified,*or*patient*is*lethargic,*inconsolable,*or*toxic*appearing,*consider*sending*to*ER.3*
Adapted*from*1Sullivan,*J.*E.,*&*Farrar,*H.*C.*(2011).*Fever*and*antipyretic*use*in*children.*Pediatrics,*127(3),*5808587.**2Chiappini,*E.,*Venturini,*E.,*Remaschi,*G.,*Principi,*N.,*Longhi,*R.,*Tovo,*P.*A.,*&*Galli,*L.*(2016).*2016*Update*of*the*Italian*pediatric*society*guidelines*for*management*of*fever*in*children.*The*Journal*of*Pediatrics,*180,*1778183.**3Ward,*M.*A.*(2017).*Fever*in*infants*and*children:*Pathophysiology*and*management.*Retrieved*from*https://www.uptodate.com/contents/fever8in8infants8and8children8pathophysiology8and8management*
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Appendix	B	
Fever	Facts	Sheet	
		
What is a Fever?!
Fever is a natural defense mechanism of the body to fight off 
infection.!
Fever is not a disease in itself, but rather a response to an illness or disease 
process.  A normal body temperature is usually about 98.6°F.  A fever is widely 
accepted to be a value at or above 100.4°F when taking a temperature from the 
rectum or ear, and 99°F when taken from the armpit.  !
Fever is not a good determinant of how ill a child is.  Some signs of serious 
illness can be lethargy, trouble breathing, severe headache, and inconsolability.
Adapted from Sullivan, J. E., & Farrar, H. C. (2011). Fever and antipyretic use in children. Pediatrics, 127(3), 580-587. and Chiappini, E., Venturini, E., Remaschi, G., Principi, N., Longhi, R., Tovo, P. A., & Galli, L. (2017). 2016 Update of the Italian 
Pediatric Society Guidelines for Management of Fever in Children. The Journal of Pediatrics, 180, 177-183. Ward, M.A. (2017). Fever in infants and children: Pathophysiology and management. Retrieved from https://www.uptodate.com/contents/
fever-in-infants-and-children-pathophysiology-and-management 
The$goal$of$fever$
medication$is$to$
improve$comfort,$not$$
to$maintain$a$normal$
temperature$$
There$is$no$evidence$
that$a$fever$causes$
brain$damage$or$
other$adverse$events$
If$your$child$is$
lethargic,$having$a$
hard$time$breathing,$
or$inconsolable$then$
consult$your$doctor$
FLUIDS AND REST 
Making'sure'your'child'is'
drinking'plenty'of'water'
will'help'prevent'
dehydration.
1
KEEP COOL 
Make'sure'your'child'is'
not'wearing'too'many'
clothes'and'that'there'is'
proper'ventilation'in'the'
room'
2
MEDICATION 
If'all'else'fails,'and'your'
child'is'still'in'visible'
discomfort,'you'may'try'
using'Tylenol'OR'Advil'as'
directed'by'weight
3
 
Fever is your Ally !
A fever facts sheet for the six month to six year old child
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Appendix	C	
Timeline	of	Events	for	Program	Completion	
	
 
 
Timeline of All 
Events 
2017 2018 
Apr May Jun July Aug Sep Oct Nov Dec Jan Feb Mar Apr May 
Successful Proposal 
Defense 
  
 
            
Develop Marketing 
Products 
              
Prepare flowsheets; 
charting forms 
              
Training and 
Education training 
for providers 
              
Implement practice 
change 
              
Follow up Needs 
Assessment (Clients 
& Providers) 
              
Assess barriers to 
implementing 
practice change 
              
Develop Database               
Collect Data               
Enter Data               
Analyze Data                
Interpret Data               
Written & Oral 
Defense 
             
 
 
Graduation               
Prepare & Submit 
Dissemination 
Products 
              
 
 
Timeline Color Key 
 Projected monthly event continuation after DNP project needs have been met 
 Projected DNP project monthly event  
 Projected one time DNP project event 
 
